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Background: HIV viral suppression reduces the likelihood of transmission to just 5%,1
demonstrating the critical link between care and prevention, yet only 51% of people living
with HIV (PLWH) were retained in care and 46% achieved viral suppression in the Houston
area (2012), with the out-of-care (OOC) population increasing between 2008-2011.2,3
Methods: Record-search investigations across HIV surveillance and care data systems
determined if potentially OOC persons referred to the Houston Health Department (HHD)
from 2013-2015 (N=1287) qualified for public health follow up. A portion were randomized
to a non-intervention group (n=200) to assess the program effectiveness. Participants without
a disposition (n=381) were assigned to a service linkage worker (SLW) for assistance with
returning to care. Multiple logistic regression assessed (1) differences between follow-up
populations (2) associations of persons relinked to care (3) statistical yield of the SLW
intervention. Firth’s penalized likelihood approach analyzed rare events where applicable.
Results: The majority of PLWH presumed to be OOC failed to qualify for follow up
primarily due to recent evidence of care (n=552, 67.3%) or having moved out of jurisdiction
(OOJ) (n=131, 16.0%). Participants referred by Disease Intervention Specialists (DIS) or
Texas jurisdictional health departments (incoming OOJ) (aOR:4.057, CI: 2.270-4.250;
referent: provider), the Enhanced HIV/AIDS Reporting System (eHARS) surveillance
referral source (aOR:2.054, CI:1.590-2.653; referent: provider), and having had an

unsuppressed viral load at last report (aOR:1.368, CI:1.058-1.769; referent: viral
suppression) had greater odds of qualifying for follow up while persons diagnosed with HIV
longer (aOR: 0.968, CI:0.950-0.986) had lower odds. Even after exhausting HHD resources
to identify persons for SL outreach (n=381, 35.1%), most persons were still unable to locate
(n=157, 41.2%) and few relinked to care (n=31, 8.1%). Of those located (n=193), the
majority self-reported already being in care (n=90, 46.6%) or refused SLW services once
successfully contacted (n=59, 30.6%). DIS/incoming OOJ referral source (aOR:7.242,
CI:2.603-20.343; referent: provider), surveillance referral source (aOR: 2.722, CI: 1.0117.186; referent: provider), and 7+ client phone calls (aOR: 3.879, CI: 1.359-12.770; referent:
two or fewer) were significantly related with returning to care via SLW. DIS/incoming OOJ
referral source (aOR=3.489, CI:1.609-7.919; referent: provider) and 7+ client phone calls
(aOR=2.341, CI: 1.130-5.003; referent: two or fewer) were associated with greater odds of
successful SLW contact while persons with a last reported viral load that was unsuppressed
(aOR:0.587, CI: 0.355-0.967; referent: viral suppression) and incrementally higher number of
client field visits had lower odds [(three or more, aOR:0.017, CI:0.005-0.048; two,
aOR:0.024, CI:0.007-0.065; one, aOR:0.074, CI: 0.022-0.0195) referent: zero]. Participants
were about half as likely to return to care by an SLW vs. those who returned to care on their
own (aOR: 0.459, CI:0.180-1.098), although results were insignificant (P-value=0.089).
Conclusions: HDs contribute key information about the OOC population, but these systems
fall short in timeliness and completeness when it comes to producing the data needed to
successfully contact and relink PLWH, requiring extensive resource management. More
information is needed about the reasons for falling OOC to better address their specific needs
and the dynamics influencing the fluid nature of HIV care.
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BACKGROUND
Literature Review
Measuring patients’ engagement with HIV care is critically important to understanding
the epidemiology of virus transmission and can identify gaps along the HIV spectrum of care,
pinpointing key areas for impactful interventions. 4,5 It has been estimated that 61.3% of all HIV
transmissions in the United States result from behaviors of individuals who were once in care for
their HIV infection but have left care. 1 This is the result of individuals having elevated viral
loads due to not being in care. It has been shown that individuals with suppressed viral loads
through antiretroviral treatment are just 5% as likely to transmit HIV as those with unsuppressed
viral loads.1 A randomized-control trial showed that PLWH who were not receiving treatment for
their HIV infection, and, therefore, did not have an undetectable viral loads were 20 times more
likely to infect their partners.6 Consequently, finding and re-engaging out-of-care individuals
with their providers is crucial to controlling the HIV epidemic.
Unfortunately, not being engaged in care is a widespread problem as demonstrated in a
study of over 100,000 HIV-infected individuals from 13 areas in the USA that documented 52%
of people who were in HIV care at one point in time did not have more than one clinic visit for
HIV care in a year.1 Federal guidelines define continuous retention in care as having 2 or more
laboratory tests (e.g., CD4+ T-lymphocyte count or viral load result) at 3 or more months apart,
and being in medical care is defined as having greater than 1 laboratory test within a defined
year.7 National estimates indicate that only 66% of HIV-diagnosed individuals who were
initially linked to care remain in HIV care, although these estimates vary widely.

8

A meta-

analysis of 28 studies showed that 41% of PLWH were no longer engaged in care, but this might
5

be an underestimate of the true number of out-of-care individuals because these data were based
on cross-sectional studies while PLWH may enter and exit the care system several times over the
course of their infection.9 In the state of Massachusetts, where healthcare access is considered
near universal, and retention rates are considered the highest in the country at 95-99%, viral
suppression was still lagging at 70%.10 These estimates were also based on a standard of care to
start antiretroviral therapy, or ART, when the CD4+ T-lymphocyte count was below 350
cells/µL with divided opinions on whether to start at higher levels. 11 At the time, at least one
expert group recommended that all PLWH should be offered ART regardless of their CD4+ Tlymphocyte count, standards which have been recently incorporated in the most recent guidelines
for the use of antiretroviral agents in adults and adolescents living with HIV by the U.S.
Department of Health and Human Services.12,13 By this new standard, the percent of PLWH
needing therapy and not being virally suppressed would be substantially higher. Being out of
care is not only a public health hazard but also results in poorer quality health and reduced
chances of survival.1,6,14–17
Determining who is out of care and how to locate them are the first steps to re-engage
HIV-infected persons with medical care, thereby accomplishing reduction in HIV incidence and
improvement of HIV-infected persons’ health. Reaching this objective is not an easy task
because people who have left care are often difficult to locate because they have moved out of
the area, are incarcerated, have relocated within the area, have changed providers, or have
died.1,6 In addition, there is no universal template for identifying, finding, and reaching out-ofcare persons because of variation in local data sources and data analysis capabilities. For
example, when multiple data sources, sampling sources, and case investigation were utilized to
6

investigate estimates of the HIV Care Continuum in King County, WA researchers found higher
estimates of HIV-positive persons linked to care, retained in care, and virally suppressed, with
almost twice the national estimates of viral suppression obtained in their population. 18 Similar
investigations confirm these results, emphasizing that assumptions of patients’ out-of-care status
are disproved by migration out of the service area, death, or incarceration. 18,19 These studies
demonstrate that multiple methods and data system investigations are needed to determine care
status, most of them adapted to the specialized systems at each locality but there is no universal
standard.
By Texas law, all laboratory tests that measure CD4+ T-lymphocyte counts and HIV viral
load results must be reported to the Department of State Health Department (DSHS), and these
results are made available to local health departments. 20 Performance of these tests at every
routine HIV clinical visit constitutes absolute minimum standard of care for HIV-infected
patients which should be performed every 3 months.20 Therefore, any patient who has not had
these tests in over a 6-month period may not be in care. However, laboratory surveillance
systems have also been found to be inefficient ways to determine who is out of care. A study that
used a single, national system of laboratory results to identify potentially out-of-care individuals
found that only 65% of eligible participants qualified for public health outreach, which included
a phone call and/or mailed letter before scheduling a baseline interview to subsequently offer
referral to a coordinated program offering comprehensive linkage to care, navigation, and partner
services, indicating that single data sources inadequately inform assessments of care status. 21 Of
the 282 cases selected for follow-up investigation, 107 required enhanced searches of local
databases for updated contact information, but, despite these efforts, 28% could not be located,
7

17% were located but had moved out of the jurisdiction, 1% were ineligible, and 2% were
deceased.21 Consequently, valuable resources were spent pursuing persons with neither the need
nor the eligibility for relinkage services, highlighting the necessity of more rigorous investigation
of available records across multiple types of data systems to improve data integrity. These
investigations can also help determine if there are any sociodemographic predictors of
engagement or gaps in care. However, record searches and data extraction also require valuable
time and training, so determining which data systems produce the most valuable information is
needed. It is also possible that the potential of laboratory and care data systems for producing the
most relevant care information differs, highlighting a gap in research knowledge.

HIV Care Continuum
Engagement with medical care is fluid, with patients filtering in and out of care
throughout their lifetime. Certain factors affect persons’ willingness to stay in care or return to
care, and Health Departments represent a unique opportunity to engage with individuals in their
jurisdiction throughout their journey over the entire HIV Care Continuum although it is
necessary to consider other factors that impact this Continuum, such as migration. 22 Their access
to comprehensive reporting data and unique relationships with HIV-care providers allows for the
design of outreach programs that are unique to the populations needing the most assistance with
navigating the medical system.
This continuum of care is a useful assessment of the HIV epidemic response developed in
recent years. Also known as the treatment cascade, it serves as a visual representation of the
marked stages of HIV diagnosis and care that can help identify gaps for HIV prevention and
treatment among populations of interest. One of the first Houston Treatment Cascades was
8

published in 2012 for the Houston Eligible Metropolitan Area (EMA) and measured five critical
points: HIV infected, HIV diagnosed, in HIV care, retained in HIV care, and suppressed viral
load.3 With the ultimate goal of reducing the number of new infections to zero, researchers and
public health officials have recognized that an HIV-infected person must first know they are
infected to begin treatment, and, once in treatment, must access ART and adhere properly to their
medical regimen to obtain and sustain viral suppression.

Figure 1. Houston EMA HIV Treatment Cascade

Figure 1 includes data reflecting the overall EMA, number and percent of people with HIV in selected stages of the continuum of HIV care,
2012 3

9

Upon release of the first Houston Treatment Cascade, the difficulty in retaining these
persons in care for uninterrupted access to ART was recognized, particularly noting that
retention and viral suppression varied across subgroups. In 2012, White (52%) and Hispanic
(53%) were more likely to be retained in care compared to Black/African American (48%), and
Black/African American were also least likely to be virally suppressed.3 Men who have sex with
men (MSM) was the risk group that was least likely to be retained in care, and, among age
groups, retention in care was lowest among youth (aged 13 to 24) and young adults (aged 25-34),
each at 54%, as well as older PLWH (aged 65+) at 53%.3
Following national guidelines calling for a new practice known as Treatment as
Prevention (TasP), the HHD launched an initiative to relink HIV-positive persons, who were
once in care but had recently fallen out of care, to an HIV care provider. To optimize resources,
multiple HIV surveillance and care data systems were utilized to record search potentially outof-care persons for recent evidence of an HIV care appointment and/or a CD4+ T-lymphocyte
count and/or HIV viral load laboratory result. These data systems were already in usage by
various entities within the HHD but were never harnessed, particularly in conjunction with each
other, for the purposes of identifying and/or confirming the current status of individuals
potentially lost to care. Other outcomes can be collected to reduce expenditure of outreach
resources, such as recent death, incarceration, or relocation to another jurisdiction. The
usefulness of each data system for producing accurate, comprehensive, and recent evidence of
care is currently unknown, but this critical knowledge is needed to determine the best practices
for measuring the out-of-care population.

10

These data systems, and quantifying their utility, are also necessary to maximize the
effectiveness of the SLW program. Once a record was searched and the person deemed likely to
be out of care, any relevant locating information was extracted from the data systems and
referred to an SLW who would subsequently attempt to locate the person and relink them to
medical care. Once a person is in care, not only is their quality of life improved, but they are
highly unlikely to transmit the virus to others because regular visits with a physician, who can
prescribe and monitor ART, can reduce a patient’s viral load to undetectable levels. However,
the yield, that is, how many additional persons are relinked to care due to SLW interactions, of
the relinkage program has not been established. The number of referrals successfully relinked to
HIV care or ancillary services to support their care, in addition to the challenges of initially
contacting and locating these clients based on surveillance and care data, is unknown.

Research

is needed to determine the effectiveness of the SLW program to establish the next steps for
expanding TasP among the populations most in need of the HHD services.
Persons determined to be out of care were counseled by an SLW on the importance of
returning and remaining in care and assisted in overcoming any barriers that prevented them
from returning to care. Research has demonstrated that barriers to retention in care for HIVpositive persons include the following: competing life activities, feeling sick, stigma, depression
and mental illness, expensive and unreliable transportation, insufficient health insurance,
forgetfulness, substance abuse, negative experiences with clinic space and processes, challenges
with appointment scheduling, difficult relationships with clinic staff including providers, and/or
inconsistent or unstable or inadequate housing. 23,24 In one study, participants reported an

11

average of 3 barriers to retention in care, indicating that assistance in navigating the healthcare
system and overcoming hurdles to HIV care is complex. 23

Service Linkage Program
The HHD identified potential ways, considered referral sources (Study Subjects), for
identifying HIV-infected individuals who have left medical care. Furthermore, there were eight
online data systems involved with collecting locating and contact information in addition to
recent evidence of care so that SLWs could assist these persons with returning to care.
Contacting individuals regarding their HIV infection status is a traditional role of health
departments. Employees of the HHD are permitted, by Texas law, to contact any person who is
potentially at risk of transmitting a sexually transmitted disease to connect those persons with
treatments that will prevent further transmission of the disease. Contacting of HIV-infected
persons is fully permissible by law.
The traditional role of the SL program is initial linkage to care following an HIV
diagnosis, established in 2008 at the HHD. Linkage-to-care rates within one year of receipt of
diagnosis are high, with most new diagnoses linked to a medical community within 12 months
(>80%).25 However, once a patient is established in a medical home, the traditional role of
sustaining care has been considered the role of the provider. Upon development of the first HIV
Care Continuum, the large discrepancy between initial linkage to care and remaining in care was
demonstrated as a significant public health problem, both for care and prevention stakeholders.
Primary data analysis indicated that people were not in care, but, once they removed themselves
from a medical network, their last primary care facility had limited information and resources to
find and re-engage them, and there was no public health safety net to catch these individuals.
12

The SL Program was originally designed to accept referrals from persons recently active
in a pre-existing public health network because of a new diagnosis. Those referrals must have
been tested recently, therefore they had been in contact with either a laboratory or a provider or a
testing program of some sort; therefore, presumably, they were within the SLW’s local
jurisdiction and likely shared viable locating information and communicated other facts about
their status that is vitally important to an SLW successfully managing their case. For persons
lost to care, there is likely sparse, outdated information and no active data. Consequently, the
purposes of this study were to create a method of identifying persons who were potentially out of
care, utilize all potential data systems to confirm this out-of-care status while simultaneously
collecting as much contact information as possible, then determine if the SLW’s skills of initial
linkage to care were transferable and adaptable to relinking persons to care.
Therefore, SLWs are individuals who can contact HIV-infected persons who are not
receiving medical care, facilitate the return of these person to care, and work to keep these
persons in care once they have re-engaged with the medical system. A subgroup of this
population was randomized to a non-intervention arm (see Study Design), which would not
receive the SLW intervention, for comparison to a subgroup of SLW-eligible individuals.
Randomly assigning some individuals to receiving the services of SLWs and others to not
receiving these services is ethical because the demand for the services of SLWs for relinkage to
care far exceeds the available resources. With or without this random assignment, most persons
who are out of care will not receive these services.
The basic process for SLW assignment after the initial surveillance investigation among
online data systems involves a supervisor. The SLW supervisor would make the initial phone
13

contact with the HIV-infected individuals and subsequently assigned these persons to an SLW.
The SLW would then schedule and meet with the clients to provide non-medical case
management within a 90-day period, based on the Ryan White Grant Administration’s (RWGA)
Standards of Care (SOC). The SOC are created by the Houston Eligible Metropolitan Area
(EMA) RWGA and are based on multiple sources, including RWGA program monitoring results,
consumer input, the US Public Services guidelines, Centers for Medicare and Medicaid
Conditions of Participation (COP) for healthcare facilities, JCAHO accreditation standards, the
Texas Administrative Code, Center for Substance Abuse and Treatment (CSAT) guidelines, and
other federal, state, and local regulations. 26 The HHD receives funding from multiple source,
including the RWGA, for various service linkage activities but adheres to these SOC to achieve
program goals, grant deliverables, and full compliance. The supervisor can determine if
additional time to relink the person to care is feasible and necessary based on the unique needs of
the client. The SLWs would travel throughout the city to meet with out-of-care persons in
environments fitting their comfort and assess their clients’ willingness to return to care and the
barriers that prevent them from seeking care. They would assist the clients in making
appointments, both medical and non-medical, and help find the resources that would enable them
to re-establish and remain in care. The SLW could assist with linkage to the following range of
services: primary medical care, abuse history or domestic violence, adherence to treatment,
dental, foster care or adoption, functional or homecare, general education, health insurance,
hearing, HIV education, hospice care, housing, legal, mental health, nutritional supplements or
food pantry, pain management, prescription assistance, rental or utility assistance, safer sex or
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family planning, substance abuse counseling, support system, transportation, vaccination, and
vision.

Houston/Harris County HIV Epidemic
In the Houston/Harris County area, 22,551 people were living with HIV as of 2013;
49.6% were Black/African American and 49.2% were aged 45 years and older.27 Most of Harris
County encompasses Houston city limits but not all. The total number of PLWH increased to
26,041 before 2016, the 11th highest rate of new HIV diagnoses in the nation, with the largest
risk category among MSM who account for the largest percent of new diagnoses at 90%. 27,28

Gaps in Knowledge
SLWs are a more recent addition to the workforce and their utility has not been fully
evaluated. Studies are needed to demonstrate the capacity of SLWs in relinking HIV-infected
individuals to medical care. However, persons who drop out of care might return to care of their
own volition, although the length of time can vary greatly. The marginal contribution of the
SLWs for relinking patients to care is unknown. Furthermore, an assessment of surveillance data
has not been done to determine if surveillance reporting have any measurable impact on the
ability of health departments to identify and successfully relink out-of-care, HIV-positive
persons to a medical provider.
Public Health Significance
The proposed study helped fill a major gap in knowledge about the potential application
of HIV surveillance and care data for identifying and relinking out-of-care persons to medical
services in the Houston/Harris County area. It contributed knowledge about whether
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surveillance and care data systems produced wide variations in data quality and helped determine
the eventual outcomes of using HIV data for relinking persons to care. Additionally, it assessed
the marginal contribution of SLWs.
The results of this study also determined if possible differences between populations who
might be out of care and those who are confirmed as currently out of care among multiple data
systems. Additionally, it explored any predictors of successful relinkage to care by the SLW
Program. Surveillance investigation and the SLW intervention are resource intensive and require
significant manpower. Quantifying their impact and determining if certain differences exist
between the populations served by this study can help prioritize future referrals to those most in
need of assistance, thereby funneling finite resources for maximum impact.
Hypothesis, Research Question, Specific Aims or Objectives
Surveillance investigation across multiple data systems was expected to reduce the
number of potentially out-of-care referrals to those individuals most likely to truly be out of care
and in need of relinkage services because it eliminated subjects with other outcomes. For
instance, a person who is deceased would not benefit from SLW services, nor would local
Houston resources be useful to someone living outside of city limits. However, only the health
department has the capacity to measure these outcomes given their access to myriad record
sources. By identifying the data systems’ ability to correctly assign outcomes for service linkage
activities, finite resources are maximized to best serve the populations most in need of relinkage.
Persons qualifying for SLW intervention are expected to have greater odds of returning to care
compared to those individuals in the non-intervention subgroup.

A.1. Specific Aim 1
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Aim 1 will employ cross-sectional analyses to assess significant differences between
participants who qualified for follow up based on surveillance investigation outcomes and those
who did not. Covariates of interest are birth sex, race, ethnicity, the most recent CD4+ Tlymphocyte count test result, the most recent viral load test result, age, referral source, and the
time since HIV diagnosis.

A.1.a. Research Questions for Specific Aim 1
Table 1. Research Questions for First Aim
Question
What databases were used for
record searches, and what
information did each system
provide?
What were the outcomes of the
databases searches (i.e., how many
referrals were administratively
closed and why?)
What databases had the most
recent evidence of care?
Which care or surveillance data
system produced evidence of care
in the most referrals?
After record searches, what are the
demographics of the assigned
referrals versus those that are
administratively closed?
Were there any significant
predictors, such as referral sources
or sociodemographic
characteristics (see Table 3) of
being classified as potentially out
of care (per database disposition)?

Data Type
Narrative

Analysis/Output
N/A

Descriptive

Number/Percent

Descriptive

Number/Percent

Descriptive

Number/Percent

Descriptive/Inferential

Number/Percent; t-test, chi square

Inferential

Logistic Regression
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A.1.b. List of Variables
Table 2. Variables for First Aim
Variable
Age
Sex
Race
Ethnicity
Referral Source
Time since HIV diagnosis
Database name
Time since last care date
Most recent CD4+ T-lymphocyte count
Most recent Viral Load

Data Type
Categorical
Categorical
Categorical
Categorical (binary)
Categorical
Continuous
Categorical
Continuous
Continuous, Categorical (binary)
Continuous, Categorical (binary)

A.1.c. List of Outcomes
Table 3. Outcomes for First Aim
Outcomes
Assigned (to SLW)
Evidence of Care
Incarcerated
Deceased
Out of Jurisdiction (OOJ)
Ineligible
Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV care

A.2. Specific Aim 2

Aim 2 will employ cross-sectional analyses to investigate potential associations of
successful relinkage to care through SLW assistance for those who were confirmed as out of care
from surveillance investigation. Possible differences between those successfully relinked and
those who were not relinked to care might identify sub-populations with additional barriers to
care and in need of further investigation to improve healthcare access. Quantifying the difficulty
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of contacting and relinking these people to care also emphasizes the need for optimal data
collection through the utilization of multiple data sources to reduce wasted resources.

A.2.a Research Questions for Specific Aim 2
Table 4. Research Questions for Second Aim
Question
What were the outcomes of all
referrals sent to SLWs
What was the mean number of
days from the first contact by
SLW to the intake? From intake
to relinkage?
Which referral source was
associated with the highest SLW
relinkage
What were the top reported
reasons for falling out of care for
those successfully contacted by
the SLW?
What were the resources
exhausted for those referred to
SLWs (number of contacts)?
Were there any significant
predictors, such as demographics
or referral source or worker
contact, of outcomes (relinkage to
care via SLW outreach)?

Data Type
Descriptive

Analysis/Output
Number/Percent

Descriptive

Mean, Median, Mode

Descriptive

N/A

Descriptive

Number/Percent

Descriptive

Mean, Median, Mode

Inferential

Logistic Regression
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B.2.b. List of Variables
Table 5. Variables for Second Aim
Variable

Data Type

Data System Results
Age
Sex
Race
Ethnicity
Referral Source
Time since HIV diagnosis
Most recent CD4+ T-lymphocyte count
Most recent Viral Load

Categorical
Categorical
Categorical
Categorical
Categorical
Continuous
Continuous, Categorical
Continuous, Categorical

Intervention Results
Reason for Being Out of Care
Days (received-intake date)
Days (intake date-medical appointment date)
Number of Phone Calls to Provider
Number of Field Visits to Provider
Number of Phone Calls to Patient
Number of Field Visits to Patient

Categorical
Continuous
Continuous
Continuous
Continuous
Continuous
Continuous

Phone calls to providers or to patients were unlimited units, but there was an upper limit
of 8 field visits per provider and per patient.

A.2.c. List of Outcomes
Table 6. Outcomes for Second Aim
Outcomes
Relinked to care
Incarcerated
Deceased
Already in care
OOJ
Refused services
Unable to locate
Other
Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV care
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A.3. Specific Aim 3
Aim 3 is an experimental design that will determine if intervention subgroup members
were more likely to return to care compared to the non-intervention subgroup members.
Quantifying the ability of SLWs to successfully return participants to care can be used for
programmatic planning purposes.
Potentially out-of-care persons were randomized as 200 intervention subjects and 200
non-intervention subjects from the eHARS surveillance referral mechanism, so this
subpopulation can be used to assess the marginal contribution (yield) of the SLWs in assisting
patients with returning to care. The non-intervention subgroup was not assigned to an SLW,
regardless of whether surveillance investigation determined a person was truly out-of-care.
Instead, after the initial investigation, a second record search was conducted 90 days later to
determine if the person returned to care on their own (Figure 3). This time period was equivalent
to when a truly out-of-care referral would have been assigned for follow up with an SLW.
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A.3.a. Research Questions for Specific Aim 3
Table 7. Research Questions for Third Aim
Question
What were the outcomes of the
intervention subjects sent to the
SLWs
What were the outcomes of the
non-intervention subjects who
qualified for 90-day follow up?
What was the mean number of
days for the intervention subjects
from the first contact by SLW to
the intake? From intake to
relinkage?
What was the mean number of
days from the date of second
Surveillance Investigation
initiation to the date the nonintervention subjects returned to
care on their own among the 90day follow up?
What were the top reported
reasons for falling out of care for
intervention subjects successfully
contacted by the SLW?
What were the resources
exhausted for intervention
subjects referred to SLWs?
Were there any significant
predictors, such as demographics
or worker contact, of outcomes
(relinkage to care via SLW
outreach)?
Randomized Subgroup - After the
90 day follow up, what was the
care status of intervention subjects
versus non-intervention subjects?

Data Type
Descriptive

Analysis/Output
Number/Percent

Descriptive

Number/Percent

Descriptive

Mean, Median, Mode

Descriptive

Mean, Median, Mode

Descriptive

Number/Percent

Descriptive

Mean, Median, Mode

Inferential

Logistic Regression

Descriptive/Inferential

Number/Percent, significant
differences to be assessed
inferentially
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A.3.b. List of Variables
Table 8. Variables for Third Aim
Variable

Data Type

Data System Results
Age
Sex
Race
Ethnicity
Referral Source
Time since HIV diagnosis
Most recent CD4+ T-lymphocyte count
Most recent Viral Load

Categorical
Categorical
Categorical
Categorical
Categorical
Continuous
Continuous, Categorical
Continuous, Categorical

Intervention Results
Reason for Refused Services
Reason for Being out of Care
Days (received-intake date)
Days (intake date-medical appointment date)
Number of Phone Calls to Provider
Number of Field Visits to Provider
Number of Phone Calls to Patient
Number of Field Visits to Patient

Categorical
Categorical
Continuous
Continuous
Continuous
Continuous
Continuous
Continuous

A.3.c. List of Outcomes
Table 9. Outcomes for Third Aim
Outcomes for Non-intervention
Assigned (to SLW)
Evidence of Care
Incarcerated
Deceased
Out of Jurisdiction (OOJ)

Outcomes for
Intervention
Relinked to care
Incarcerated
Deceased
Already in care
OOJ
Refused services
Unable to locate
Other

Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV care

METHODS
Study Setting
Houston is the fourth largest city in the United States and is the county seat of Harris
County. The County has approximately 4.5 million residents. It is one of the most diverse areas
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in the United States with a population of 30.4% non-Hispanic white, 42.4% Hispanic, 19.7%
African-American, and 7.2% Asian.29 One-quarter of the population is foreign born and 43.4%
of the population speaks a language other than English at home. 29 As of 2012, there were
approximately 23,000 PLWH in Houston/Harris County and about 30% of those who were once
in care were currently out of care.30 An estimated 74.1% of PLWH were male, 49.8% were
Black/African American, and 31.7% were aged 45-54, with the highest transmission risk among
MSM (51.3%).30
Study Design
A cohort (N=1287) of potentially out-of-care PLWH in the Houston/Harris County area
was selected from various referral sources (see Data Collection) from 20 June 2013 through 14
July 2015. Online records were reviewed among eight data systems to determine if 1087 of
these referrals qualified for SLW intervention, and, subsequently, if qualified referrals were
successfully relinked (i.e., attendance at an appointment with a medical provider) to HIV medical
care. Using simple randomization, a subgroup of these referrals (n=400) were randomly selected
from the same referral source, eHARS (see Data Collection), and randomly assigned to an
intervention arm (n=200) or non-intervention arm (n=200). Analyses were restricted to living
prevalent cases in City of Houston/Harris County who were 18+ years of age as allowed by
governing public health policy. All CD4+ T-lymphocyte counts and viral load results with a
valid month and year for specimen date were considered. Anyone with a last known address
outside of Houston/Harris was also excluded.
The non-intervention subgroup did not receive the SLW intervention, but, if record
searches in Data System Investigation A (see Figure 3) confirmed the non-intervention subject
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was likely to be truly out of care, they received an additional surveillance investigation follow up
among the same data systems at 90 days after the initial record search (Data System
Investigation B, see Figure 3) to determine if they returned to care on their own in comparison to
intervention subjects. Three months is the usual timeframe for Ryan White service linkage, with
a standard goal to close a case investigation by 90 days. Relinkage to care was modeled after RW
service linkage; however, it was logistically easier to be granted an extension past 90 days for
relinkage to care, which is a limitation of modeling a 90-day follow-up period for nonintervention subjects.
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Figure 2. Flowchart of Study Population
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Data Description
Criteria for referral: The study unit is PLWH who were located in the Houston/Harris
County area during their last evidence of care but who lacked any evidence of care within the six
months (183 days) or more prior to the date of referral to the HHD for surveillance investigation.
Evidence of care from surveillance investigation (SI): Evidence of care as determined
during surveillance investigations was defined as a medical appointment completed with a
healthcare provider for HIV-related follow up and/or a CD4+ T-lymphocyte count and/or viral
load laboratory result within the six months prior to the date of surveillance investigation among
online records, not the date the referral was received by the HHD.
For the non-intervention subjects, 200 potentially out-of-care persons were investigated
(Data System Investigation A) among online data systems for an outcome. If no outcomes were
found, the person was presumed to still be out of care. Unlike the intervention subgroup, nonintervention subjects lacking any outcome after the initial investigation (Stage A) were not
assigned to the SL Program. However, they were re-investigated (Data System Investigation B)
among online data systems 90 days after the initial date of investigation (Date A). The primary
measure of interest was binary: Yes (the patient had any outcome within the previous 90 days,
e.g., in care, out of jurisdiction, deceased, etc.) or No (the patient lacked any outcome so was
presumed to still be out of care).
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Figure 3. Non-intervention Subgroup - primary timeline of investigation with 90-day
follow up

Referral Received
Variable: Date of Receipt
Referral Source: eHARS
(Surveillance Linelist)

Data System Investigation (A)
Data System(s): All
Variable: Date of Surveillance
Investigation (A)
Binary Outcome
• Yes: Outcome (e.g., evidence of care
within the previous 183 days,
incarcerated, deceased, etc.)
• No: Lacks an SI outcome so qualifies
for additional follow up in 90 days (i.e.,
patient presumed to be out of care)

Data System Investigation (B)
Data System(s): All
Variable: Date of Surveillance
Investigation (B)
Binary Outcome
• Yes: Outcome (e.g., evidence of care
within the previous 90 days,
incarcerated, deceased, etc.)
• No: Lacks an SI outcome so patient
presumed to still be out of care

Study Subjects
The study investigated four sources of referrals of potentially out-of-care PLWH and
assessed whether further investigation across multiple data systems confirmed that a referral
truly appeared to be out-of-care or had evidence of other outcomes.
Surveillance Referrals. Under Chapter 97 of Texas Administrative Code, all CD4+ Tlymphocyte count and HIV viral load laboratory results are subject to required reporting to the
local health authority. In Houston/Harris County, the local health authority is the City of
Houston Health Department. If individuals had at least one of these tests reported from 1 July
2011 through 31 June 2012 in a surveillance database, eHARS, they were considered in care
during this time period, arbitrarily defined in the beginning of the study. It was assumed that
having had more recent evidence of care, relative to falling out of care and qualifying for
inclusion in this study, would adhere most closely to the HHD’s commitment to offer services as
28

soon as they are determined to be needed. Laboratory records for these individuals were
subsequently reviewed again from 1 July – 31 December 2012. The second time period was
selected because current recommendations state laboratory results should be performed every 3 6 months, so missing these tests within the six months after a previous appointment were proxy
indicators of missing care. Over 6,000 persons were identified, a population substantially larger
than available resources for subsequent investigation. Therefore, 200 intervention subgroup
members were randomly selected for public health follow up to determine the utility of this
source for locating out-of-care persons. These individuals were referred in one batch to
surveillance investigation, and, due to limited personnel and staff time, only a few persons could
be record searched per day resulting in a varied delay period.
Provider Referrals. Three HIV providers, funded by Harris County Public Health
through the Ryan White Care act, transmitted lists of patients to the HHD of persons their
respective systems deemed to have fallen out of care. These providers included Harris Health
System, St. Hope Foundation, and Houston Area Community Services. Each of these
organizations is required, as a condition of receiving funds from Houston’s Ryan White Grant
Administration in the local area, to identify their patients who have seemingly dropped out of
care. They must attempt contact with each of these individuals three times by more than one
method (e.g., phone, mail, email, text, home visit) to encourage them to return to care. The HHD
created Point-of-Entry agreements with each of these organizations in order to establish
guidelines for sharing of client-level data in accordance with health authorities mission to control
and treat communicable disease (Chapter 81 of the Texas Health and Safety Code). These
agreements made it possible for the HHD to obtain a list of potentially out-of-care individuals
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from each provider. In total, 806 persons were referred by these providers. These individuals
were referred in batches to surveillance investigation, and due to limited personnel and staff
time, only a few persons could be record searched per day resulting in a varied delay period.
Disease Intervention Specialist (DIS) Referrals. DISs are responsible for obtaining the
names and contact information of the partners of persons diagnosed with sexually transmitted
diseases (STD) and subsequently notifying and testing partners of possible exposure. This
process, known as partner elicitation and notification, interrupts disease transmission in the
community. In Houston/Harris County, DIS attempt to locate and interview all suspected cases
of HIV and syphilis as part of the elicitation and notification process. Those already living with
HIV who are pregnant or have a new reportable STD (chlamydia, gonorrhea, or syphilis) are also
initiated for intervention. During an encounter with a newly STD-diagnosed patient or partner, a
DIS might discover a previously diagnosed PLWH who reveals that he or she is no longer
receiving HIV-related medical care. DIS referred 70 persons to this study. DIS referrals were
submitted individually and surveillance investigation was completed within 24 hours of receipt
during business hours.
Incoming Out of Jurisdiction (OOJ) Referrals. Migration is a major factor that impacts an
individual’s ability to establish care efficiently and effectively. State and/or local jurisdictions
have routinely shared data so that health departments do not duplicate clients in surveillance
records and so that they may share information to locate partners of newly diagnosed cases.
More recently, some health departments have used this established communication pathway to
also ensure that PLWH who have moved between jurisdictions receive assistance to navigate the
local care system. 11 individuals were referred from this source. OOJ referrals were submitted
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individually and surveillance investigation was completed within 24 hours of receipt during
business hours.
All referrals were 18 years of age or older and not pregnant. They had documented
evidence of care through a medical record, provider account, confirmation from another health
department, or CD4+ T-lymphocyte and/or viral load laboratory result at some previous point in
time and had evidence of a positive HIV diagnosis.
These referrals served as the starting point for determining who was actually out of care.
Subsequent record searches across multiple care and surveillance data systems provided
additional information on current care status and locating information. If a referral had evidence
of an attended medical appointment for HIV care or CD4+ T-lymphocyte or viral load laboratory
results within the immediate six months prior to the investigation date, they were considered
currently in care. If available records confirmed a PLWH was likely to be out of care, they were
assigned to an SLW. SLWs are non-medical case managers who specialized in finding and
facilitating HIV-positive clients’ return to care for this study intervention.

Sample Size Calculation and/or Study Power

Subgroup of Intervention and Non-Intervention Members
Although literature is sparse given the lack of experimental designs to measure the impact of
non-medical case managers on relinking HIV-positive persons to care, assuming the expected
proportion of those unexposed to an SLW who return to care is 0.05, the expected proportion of
those exposed to an SLW who relink to care is .15, a 95% confidence level, and a desired power
of 0.80 (i.e., the percent chance of detection), the sample size per group should be 141
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participants, and the total sample size should 282 participants at minimum.31

Exposure to a non-

medical case manager was defined as any initial attempt at contact by said worker, such as any
phone call or mailed letter or home visit, etc. The expected proportion of those exposed to an
SLW who relink to care with an outcome was estimated from literature published closest to
study initiation, ranging from 15-16% as reported by relinkage to care programs similar in design
amongst urban populations.32,33 The proportion of unexposed with an outcome was unknown
and informed by internal surveillance data.
This method was used with the following formula, for the required sample size:
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𝑧∝ √𝑃0 (1 − 𝑃0 ) + 𝑧𝛽 √𝑃1 (1 − 𝑃1 )
𝑛′ = [
]
𝑃1 − 𝑃0

According to Fleiss, Levin, and Paik (2003), 𝑧∝ is the “critical value of cutting off the probability
alpha in the upper tail of the standard normal distribution,” (Chapter 2, Section 5) and 𝑧𝛽 is the
“critical value of cutting off the probability beta in the upper tail of the standard normal
distribution” (Chapter 2, Section 5).31
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2
𝑛=
(1 + √1 +
)
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n′|𝑃1 − 𝑃0 |
Here, 𝑃1 is the estimated proportion relinked to care in the exposed, and 𝑃0 is the estimated
proportion returned to care in the unexposed.31
The resulting odds ratio would be 3.4 based on the contingency table below:
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Data Collection
Eight online data systems were record searched to gather information about each referral.
Two of these systems serve as repositories of laboratory results while two others store medical
care records. The care and laboratory data systems provided recent evidence of care or
confirmed that a referral was likely to be out of care, thus qualifying for SLW intervention. All
databases were used to collect client contact information and other identifying factors so there
would be substantial evidence to verify that each person found in each system was the correct
identity and to determine if the referral might be ineligible for relinkage services because of
other outcomes (e.g., incarcerated, deceased, out of jurisdiction, or ineligible due to pregnancy,
under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV
care). Persons who were 18 or pregnant were excluded for research purposes. The outcome of
interest was whether surveillance investigation produced evidence that a referral was currently in
care or currently out of care.
eHARS. Known as the Enhanced HIV/AIDS Reporting System, eHARS is a national
HIV surveillance system that houses HIV testing results, patient demographics, and patient
contact information. These data are imported or entered based upon reports from providers,
laboratories, or other sources of HIV testing as required by Texas Administrative Code. Aside
from HIV diagnostic tests, reportable since 1999, CD4+ T-lymphocyte and viral load laboratory
results have been mandatory since 2010, 34 and these laboratory results can serve a proxy for the
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most recent evidence of care. The primary contribution of this system was HIV diagnostic and
laboratory measures of care.
Maven. This software is a customizable disease surveillance and case management
system. The HHD’s Maven system, Houston Electronic Disease Surveillance System (HEDSS),
includes a module that serves as a repository for electronic laboratory reports of HIV. It collects
and houses results from commercial, state, and local hospital laboratories. For this study’s
purposes, “most recent evidence of care” was defined as the most recent CD4+ T-lymphocyte,
viral load result, or CD4:CD8 ratio laboratory result housed in HEDSS. It is considered a realtime source of laboratory results given automatic electronic imports of these data from linked
hospital and/or healthcare systems within the local jurisdictional area. The primary contribution
of this system was HIV diagnostic and laboratory measures of care.
CPCDMS. Known as the Centralized Patient Care Data Management System, CPCDMS
is overseen by the Ryan White (RW) Grant Administration to store RW-funded client
information and track medical appointments among their consumers, including RW eligibility
documentation and care attendance at RW-funded providers. From this system, “most recent
evidence of care” was defined as the most recently attended HIV medical care appointment, the
primary contribution of this system.
Epic. This software houses and manages electronic health records and is the system used
by the Harris Health System. It is employed as a care database and produces records of
consumer visits within the Harris Health System provider network, collectively serving the
Harris County area which includes most of the geographic spread of Houston. Epic captures all
patient office visits, irrespective of HIV status or history, so “most recent evidence of care” was
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defined as only the most recently attended medical appointment described as a primary care visit
for HIV, the primary contribution of this system.
STD*MIS. A free database application, or Medical Information System, supported by
the Centers for Disease Control and Prevention (CDC). The Texas DSHS maintains the system
for local and state usage for STD surveillance and public health investigation throughout Texas.
Data is collected by the HHD to track public health follow- up activities and outcomes of partner
elicitation and notification. This data system contains relevant contact information,
identification of aliases and/or other names, patient histories, STD morbidity reports, and some
details regarding past HIV care and HIV/STD diagnostic and laboratory results. Since a
substantial amount of the care information is self-reported and the laboratory results are not
comprehensive, for the purposes of this study, it was primarily used to collect contact
information and client identifiers.
Accurint. This comprehensive database of over 37 billion public records provides the
most recent contact and locating information to verify a person resides within the service
jurisdiction limits while increasing the likelihood that an SLW will be able to find the person if
the individual qualifies for relinkage services.

The primary contribution of this system of client

contact information. Furthermore, it supplies mortality records, potential incarceration status,
and additional aliases.
JIMS. The Justice Information Management System is the Harris County Sheriff’s
Office’s public information inquiry. It provides the most recently updated incarceration status
for inmates of Harris County Jail for usage by the general public. Information is updated during
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working days only, so information is over 24 hours old. The primary contribution of this system
was current incarceration status.
TDCJ. The Texas Department of Criminal Justice online offender search is the State of
Texas’ public information inquiry. It provides the most recently updated incarceration status for
inmates of the TDCJ facilities for usage by the general public. Information is updated during
working days only, so information is at least 24 hours old. The primary contribution of this
system was current incarceration status.
All data systems contributed information regarding client contact/locating information,
demographics, vital statistics, incarceration status, and eligibility except for JIMS and TDCJ
which could only contribute incarceration-related details.

Collected information from each data

system was stored in an encrypted and password protected database using Microsoft Access
2010 software. After record searches were completed, the final outcome of each person was
entered into STD*MIS. Referrals that qualified for the intervention were securely assigned to
the SLW program through STD*MIS with the most recent contact and locating information
available attached to the transmission. Per referral, all data systems were record searched and
assigned a final outcome within a single business day so the data utilized by the SLWs was the
most recent and complete.
Data Analysis
The patient population was the 1287 initial potentially out-of-care persons. Data was
collected from the data systems described in section I. All analyses were performed using SAS
9.4 software. Data was stored in a secure and encrypted Microsoft Access database.
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Demographic characteristics were age, birth sex, race, ethnicity, referral source, age, time
since HIV diagnosis, most recent CD4+ T-lymphocyte count, most recent viral load result, client
phone calls, client field visits, provider phone calls, and provider field visits. Laboratory
measures were reviewed for potential meaningful categorical breakdowns. CD4+ T-lymphocyte
count and viral load laboratory results are extraordinarily useful clinical and public health
measures when categorized. HIV infection, according to the CDC, is classified in 3 stages, with
the 3rd Stage (AIDS) indicating when a person’s immune system has become severely
compromised as marked by a low CD4+ T-lymphocyte count (<200 cells/µL) or opportunistic
infection.35,36 Therefore, CD4+ T-lymphocyte count was recategorized as <200 cells/µL, >200
cells/µL, and none reported (Table 11). Viral load laboratory results are important measures of
HIV medication adherence, quality of health, and risk of transmission to others, with the ideal
goal of viral suppression, as defined by the CDC as having a plasma HIV RNA of either <200
copies/mL or 400 copies/mL.37 The CDC’s endorsement of the international Prevention Access
Campaign, Undetectable=Untransmissable, or U=U, emphasizes an undetectable viral load
blocks HIV transmission, and it is based on the value of <200 copies/mL, so this threshold was
selected.38 Therefore, viral load laboratory results were categorized as <200 copies/mL, > 200
copies/mL, and none reported (Table 11).
Age was presented as continuous and categorical for participant characteristic tables but
only considered in its categorical format for statistical analyses per literature standards of known
studies of similar outcomes.32,39 The following categories for this study were chosen to reflect
the HIV EMA Care Continuum except for the youngest category which, for this study, had a
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cutoff of 18 given exclusion criteria. These groupings reflect community measures which might
prove useful for interpretation and practical application.25
For univariable analyses, simple logistic regression or chi-square analyses assessed initial
relationships between independent variables and dependent variables with significance set at Pvalue <.25, as levels lower than this threshold might not detect variables of potential
importance.40–42 For independent categorical variables, contingency tables were also used to
identify possible areas of sparse data which might cause numerical instability in the multiple
logistic regression model. Categories with cell sizes fewer than 5 were absorbed in the next
related category if possible and logical to the sequence of data or assessed using Fisher’s exact
test. Significant variables in the univariable analyses were selected for inclusion in the primary
multiple logistic regression model.
Multiple logistic regression assessed significant differences between binary outcome
measures. The Hosmer-Lemeshow test was used to assess goodness of fit, adequate for nonreplicated data, with P-value >0.05 indicating no evidence of lack of fit.43 If all independent
variables were significant in the initial multiple logistic regression model and the HosmerLemeshow test signaled no concern for lack of fit, then this model was considered the final
model, unless multicollinearity diagnostics required adjustments. If any independent variables
were not significant in the primary multiple logistic regression model, backwards elimination
removed variables from the primary equation using the automatic variable selection tool in SAS
9.4 software, code “selection=backward fast slstay=0.2”.44,45 To describe this process in detail,
the variable with the smallest significance, or largest P-value, was eliminated and the model was
refitted with all statistics recalculated. The procedure was restarted, eliminating another
38

variable, until the only remaining factors were those with a P-value >0.20. Given the
exploratory nature of this study and small number of starting independent variables, with little
known about the potential associations of these factors and no specific exposure->outcome
relationship of interest except for specific aim 3, the cutoff for inclusion in the final model was
set at a moderate significance of 0.20. The linear relationship between continuous independent
variables and the logit was evaluated using loess plots; no transformations needed to be
considered.
To test for multicollinearity, the variance inflation factor (VIF) and tolerance were
examined as diagnostics measures, with VIF>2.5 and tolerance<0.1 investigated further. The
condition index and regression coefficient variance-decomposition matrix were subsequently
assessed for additional information about these relationships. For the condition index, a
representation of the collinearity between combinations of variables, the threshold was set at
15.46 If a condition index exceeded this threshold and was responsible for a large proportion of
variance (>0.90) in two or more coefficients, collinearity was considered present. 46 Spearman
correlations, for ordinal variables, and Pearson correlations, for continuous variables, provided
additional insights into the specific relationships between independent variables, in addition to
other underlying considerations of importance such as known literature. Problematic bivariate
correlations resulted in deletion of one of the two variables. Collinearity and correlation
diagnostics are discussed in the results section when potentially problematic associations were
identified and required resolution.
If missing data were less than 5%, then they were assumed to be missing at random and
list-wise deletion eliminated these observations from final analysis.
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Primary outcomes of interest per specific aim are further described below by specific
aim.

B.1. Aim 1
The patient population was the 1287 initial referrals with outcomes and covariates
originating from data collection via surveillance investigation databases.

B.1.a. Statistical Analysis
For univariable analyses, simple logistic regression or chi-square analyses assessed initial
relationships between independent variables and the dependent variable with significance set at
P-value <.25. Categories with cell size counts fewer than 5 were absorbed in the next related
category if possible and logical to the sequence of data or assessed using Fisher’s exact test.
Associations between significant relations were further examined together in multiple logistic
regression.
Multiple logistic regression assessed significant differences between participants who
qualified for follow up and participants who did not qualify. The primary outcome was binary:
No, the client did not qualify for follow up, or Yes, the client qualified follow up (N=1287). The
secondary analyses focused on the sub-group of referrals who qualified for follow up and those
who did not due to recent evidence of care. The secondary outcome was binary: No, the client
did not qualify for the follow up due to recent evidence of care within the previous 183 days, or
Yes, the client qualified follow up (n=1019). Covariates of interest were birth sex, race,
ethnicity, the most recent CD4+ T-lymphocyte count test result, the most recent viral load test
result, age, referral source, and the time since HIV diagnosis.
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B.2. Aim 2
The patient population was the 381 referrals assigned to SLW relinkage services after
qualifying for follow up post-surveillance investigation. Data were collected via paper charts
that was manually entered into the STD*MIS data system by the SLW assigned to the individual
referral. Possible outcomes were that a client was relinked to care versus not linked due to other
outcomes such as the client reported already being in care, refused SLW assistance, unable to
locate, etc. (n=381). Secondary analyses assessed whether persons who qualified for the SL
Program were located by an SLW. The outcome was binary: No, the client was not located by
an SLW, or Yes, the client was located by an SLW (n=381).

B.2.a. Statistical Analysis
For univariable analyses, simple logistic regression or chi-square analyses assessed initial
relationships between independent variables and the dependent variable with significance set at
P-value <.25. Categories with cell size counts fewer than 5 were absorbed in the next related
category if possible and logical to the sequence of data or assessed using Fisher’s exact test.
Associations between significant relations were further examined together in multiple logistic
regression.
Primary multiple logistic regression analysis assessed the likelihood of being relinked to
care for referrals who qualified for the intervention. The primary outcome was binary: Yes (the
patient was relinked to care) or No (the patient was not relinked to care). Secondary multiple
logistic assess the odds of being located by SLW outreach. The primary outcome was binary:
Yes (the patient was located) or No (the patient was not located). Being successfully located was
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defined as at least one incident of verbal and/or physical contact via phone and/or field visit by
an SLW with the persons of interest. Identity was confirmed by the SLW via date of birth and
legal name. Other documentation might also be used.
Persons lost to care can be difficult to find due to substantial lengths of time missing from
the medical system and/or sparse locating information, despite extensive surveillance
investigation prior to referral. Determining if the time and resources spent by the SLWs in their
attempts to contact these persons is fruitful and/or whether other characteristics might yield
higher response could assess best practices moving forward.
Due to the small proportion of those successfully relinked to care, as stated previously,
variables were recategorized where possible. If recategorization failed to correct for expected
cell counts fewer than 5 and/or resulted in unmeaningful categories if reduced further, Fisher’s
exact test was substituted for chi-square analysis during univariable analyses. However,
continuous variables were assessed using Firth’s penalized likelihood method, proposed by King
and Zeng in 2001, to reduce the bias of the small sample size. 47 According to Greenland and
Mansournia in their evaluation of Firth’s method versus traditional maximum likelihood
estimation (MLE) in logistic regression analyses, MLE fails to minimize expected error or loss. 48
With small sample sizes, weak penalties subsequently yield questionable estimates, but Firth’s
penalty (see Appendix C) offers an alternative approach.48–50 Consequently, the final logistic
regression model also applied the Firth method due to the small sample size.47
The backwards selection tool cannot be employed in SAS 9.4 in combination with the
Firth method, therefore backwards selection was performed manually using the same selection
criteria of a P-value>0.20. The procedures were the same as described previously, with the
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variable with the smallest significance, or largest P-value, eliminated first and the model refitted
with all statistics recalculated. The procedure was restarted, eliminating another variable, until
the only remaining factors were those with a P-value >0.20. For additional guidance, the
adjusted R-squared and Akaike information criterion (AIC) were reviewed upon deletion and
restructuring of the model as relative measures of fit, with higher R-squared values and lower
AIC values generally indicating better model selection.
The yield of the SL program was assessed in terms of cumulative resources spent (i.e.,
number of contacts and number of field visits to the provider and patient, respectively)
attempting to relink clients to care and stratified via outcomes and/or categories of interest,
depending on exploratory analyses.

B.3. Aim 3
The patient population was the 200 intervention subgroup members and 200 nonintervention subgroup members (see Study Design under METHODS). For intervention subjects
who qualified and were referred to the SL Program, data was collected via paper charts that was
manually entered into the STD*MIS data system by the SLW assigned to the individual case.
Possible outcomes included a client was successfully relinked to care versus other outcomes such
as a client reported already being in care, refused SLW assistance, unable to locate, etc. Subject
information was collected via data systems for non-SLW outcomes (i.e., surveillance
investigation prior to SLW referral). For non-intervention subgroup members, the information
was collected solely via data systems.

B.3.a. Statistical Analysis
43

A comparison of the subjects randomized into the intervention group (n=200) and nonintervention group (n=200) from the same referral mechanism (i.e., surveillance list generated
from eHARS data source, see Data Analysis under METHODS) was performed to assess if
differences existed between the samples which could impact the results. For continuous
variables, a two-sample t-test was performed to determine if mean differences existed in the nonintervention group versus the intervention group among normally-distributed variables. Nonnormal variables were analyzed using the Wilcoxon rank-sum test and, where possible, also in its
categorical format. A difference of proportions between these variable types were assessed using
the chi-square test.
For univariable analyses, simple logistic regression or chi-square analyses assessed initial
relationships between independent variables and dependent variables with significance set at Pvalue <.25. Due to the small proportion of those successfully relinked to care, variables were
recategorized where possible. If recategorization failed to correct for expected cell counts fewer
than 5 and/or resulted in unmeaningful categories if reduced further, Fisher’s exact test was
substituted for chi-square analysis during univariable analyses. Continuous variables were
assessed using Firth’s penalized likelihood method. Associations between significant relations
were further examined together in multiple logistic regression.
Multiple logistic regression analyses compared intervention subjects and non-intervention
subjects to determine the odds of returning to care. Covariates of interest are birth sex, race,
ethnicity, age, referral source, and the time since HIV diagnosis. The final logistic regression
model applied the Firth method due to the small sample size, with steps described in B.2.a
Statistical Analysis.47
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Human Subjects, Animal Subjects, or Safety Considerations
The parent study, under which all data was collected, was titled “Determining the most
efficient and effective ways of identifying and returning HIV-infected persons to care:
Evaluation of the Expanded Linkage to Care Initiative (ELCI),”and received approval to begin
research from the Committee for the Protection of Human Subjects of the University of Texas
Health Science Center at Houston on 25 September 2013. This study was processed for closure
by the Committee on 1 December 2015. The proposed analyses herein were submitted for
review to the Committee for Protection of Human Subjects of the University of Texas Health
Science Center at Houston and was determined to qualify for exempt status.
The HHD conducts regular public health activities under Chapter 81 of the Health and
Safety Code. Data are stored under a local area network system with restricted access to the
network, including but not limited to authorized usernames and firewall-protection. The
databases for storing the collected and analyzed data are password-protected and encrypted
within these networks, managed and tracked by the HHD’s information technology division, and
accessible only through a pre-determined approval process which includes mandatory client
safety and confidentially training.

RESULTS
A cohort (N=1287) of potentially out-of-care PLWH in the Houston/Harris County area
were referred from 20 June 2013 through 14 July 2015. Most referrals were male (73.3%), black
(60.0%), and non-Hispanic (77.2%), with a mean age of 42 years.
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Table 10. Participant characteristics overall and by initial surveillance investigation
outcome
Demographic
Characteristics

Total
N=1287

Age*
18 to 24
25 to 34
35 to 44
45 to 54
55 or older
Sex
Male
Female
Race
Black
White
Other
Ethnicity
Non-Hispanic
Hispanic
Referral Source
Provider
DIS/OOJ
Surveillance

Age (years)
Time since HIV
diagnosis (years)
Most recent CD4 count
(cells/µL)
Most recent Viral Load
(copies/mL)

Qualified for Follow
Up1
n=467
n
%

Other Outcome2
n=820
n

n

%

%

91
311
347
336
202

7.1
24.2
27.0
26.1
15.7

39
131
131
107
59

8.4
28.1
28.1
22.9
12.6

52
180
216
229
143

6.3
22.0
26.3
27.9
17.1

943
344

73.3
26.7

349
118

74.7
25.3

594
226

72.4
27.6

771
499
17

60.0
39.0
1.3

281
177
9

60.2
40.0
1.9

490
322
8

59.8
39.3
1.0

994
293

77.2
22.8

353
114

75.6
24.4

641
179

78.2
21.8

806
81
400

62.6
6.3
31.2

236
52
179

50.5
11.1
38.3

570
29
221

69.5
3.5
27.0

Mean

[SD]

Mean

[SD]

Mean

[SD]

41.7
10.0

+11.9
+6.8

40.1
8.9

+11.8
+6.3

42.7
10.6

+11.9
+7.0

444.8

+360.8

462.4

+397.6

434.9

+338.4

75713.0

+489112.0

45540.6

+150437.6

92624.9

+600019.0

1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes
referral to the SL Program for further case investigation. For non-intervention subjects, follow up includes an additional surveillance
investigation 90 days after the initial record search date.
2. Referrals were not assigned to follow-up due to an initial surveillance investigation outcome of recent evidence of care, incarceration, death,
migration (OOJ), or ineligibility.
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Of the total participants with a surveillance investigation outcome disqualifying them
from additional follow up, 15 (1.8%) were incarcerated, 104 (12.7%) deceased, 552 (67.3%) had
evidence of care, 131 (16.0%) were out of jurisdiction, and 18 (2.2%) were classified as ‘other.’
The ‘other’ category included pregnancy, being under 18 years of age, having no evidence of an
HIV diagnosis, and no locating information was received upon referral nor found during
surveillance investigation. For more information about exclusion criteria, please see Data
Collection.
CD4+ T-lymphocyte count and viral load laboratory results were only considered for
subsequent analyses in their categorical formats due to the health importance of their clinical
categories.
Table 11. Subgroups – breakdown of participant characteristics into clinical categories
for select independent variables
Demographic
Characteristics

Total
N=1287
n

Most recent CD4 count
>200 cells/µL
<200 cells/µL
None reported
Most recent Viral Load
>200 copies/mL
<200 copies/mL
None reported

%

Qualified for Follow
Up1
n=467
n
%

Other Outcome2
n=820
n

%

919
320
48

71.4
24.9
3.7

348
96
23

74.5
20.6
4.9

571
224
25

69.6
27.3
3.1

599
626
62

46.5
48.6
4.8

231
209
27

49.5
44.8
5.8

368
417
35

44.9
50.9
4.3

1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes
referral to the SL Program for further case investigation. For non -intervention subjects, follow up includes an additional surveillance
investigation 90 days after the initial record search date.
2. Referrals were not assigned to follow-up due to an initial surveillance investigation outcome of recent evidence of care, incarceration, death,
migration (OOJ), or ineligibility.
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Results for Aim 1
Table 12. Significant factors associated with qualifying for follow up (N=1287) based on
univariable analyses

Characteristic
Agec (years)
Time since HIV diagnosis (years)
Referral Source
Most recent CD4 counta
Most recent Viral Loadb

χ2

β (SE)

P-value

13.8475
N/A
56.7996
9.2716
5.0355

N/A
-0.0382 (0.0090)
N/A
N/A
N/A

0.0078
<.0001
<.0001
0.0097
0.0806

a

Most recent CD4 count is the most recent CD4+ T-lymphocyte count in cells/µL categorized as >200 cells/µL, <200 cells/µL, or no evidence
found of ever having had a CD4+ T-lymphocyte count reported.
b
Most recent Viral Load is the most recent viral load laboratory result in copies/mL categorized as >200 copies/mL, <200 copies/mL, or no
evidence found of ever having had a viral load reported.
c
Age was analyzed in its categorical format only, 18-24, 25-34, 35-44, 45-54, 55+

Collinearity diagnostics produced values of VIF<2.5 and tolerance values greater than
0.1. Furthermore, the largest condition index value was 7.61806 with the highest, non-intercept
proportion of variance equaling 0.60590 for age followed by time since HIV diagnosis at
0.59932 before dropping substantially to 0.05564 for referral source. Indications were not strong
for collinearity, but given these results, the relationship between age and time since HIV
diagnosis was examined further among correlation matrices, which supported a significant
relationship between age and time since HIV diagnosis (P-value <.0001).
Since HIV infection is a lifelong diagnosis, a correlation between age and time since HIV
diagnosis is logical, and these variables might be useful proxy measures for each other given one
ages with the disease. However, a person could be older and newly diagnosed with HIV, ergo
not everyone of older age is necessarily a long-term survivor. Given an interaction term would
contribute no useful clinical interpretation and one method of dealing with correlated
independent variables is deletion of one of the two variables,51 only time since HIV diagnosis
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was retained in the multiple logistic regression models where both were significant since it is a
useful measure of longevity with the infection. However, age was still considered during
univariable relationship assessments and reflected in the narrative where significant for model
transparency as it might be considered for future analyses or of interest to researchers conducting
similar studies.
Other significant variables identified in the simple analyses and retained in the multiple
logistic regression model were referral source, most recent CD4+ T-lymphocyte count, and most
recent viral load laboratory result. All other independent variables were insignificant (Pvalue>.25).
Table 13. Regression analyses of factors associated with qualifying for follow up
(N=1287)

Characteristic
Time since HIV diagnosis (years)
Referral Source
Provider
DIS/OOJ
Surveillance
Most recent CD4 count
>200 cells/µL
<200 cells/µL
None reported
Most recent Viral Load
<200 copies/mL
>200 copies/mL
None reported

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

0.968

0.950,0.986

0.0007

referent
4.057
2.054

referent
2.270,7.250
1.590,2.653

referent
<.0001
<.0001

referent
0.752
0.875

referent
0.555,1.020
0.321,2.386

referent
0.0667
0.7944

referent
1.368
0.874

referent
1.058,1.769
0.357,2.142

referent
0.0168
0.7689

There were 15 observations deleted due to missing values for the response or explanatory
variables. Post-investigation revealed these missing observations were from the explanatory
variable time since HIV diagnosis.

49

Results from multiple logistic regression indicate that time since HIV diagnosis (β=0.6505, SE=0.1370, P-value=0.0007), referral source (DIS/OOJ: β=1.4004, SE=0.2962, Pvalue=<0.0001; Surveillance: β=0.7197, SE=0.1307, P-value=<0.0001), and having an
unsuppressed (>200 copies/mL) viral load (β=0.3133, SE=0.1311, P-value=0.0168) last reported
were associated with qualifying for follow up. DIS/OOJ and provider referrals had greater odds
of qualifying for follow up compared to provider referrals, as did persons with an unsuppressed
viral load as last reported at the time of surveillance investigation when compared to those with
suppressed viral loads. However, persons diagnosed with HIV longer had lower odds of
qualifying for follow up. All other results were insignificant (P-value>0.05).
Incoming referrals were presumed to be out of care, yet each referral source presents its
own limitations for being able to determine the accurate and current care status of their
respective clientele. An assessment was performed to determine if certain characteristics,
particularly referral source, were associated with having recent evidence of care (i.e., not
qualifying for follow up) despite being presumptively identified as having fallen out of care.
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Table 14. Participant characteristics of referrals sent for follow up or closed because of
evidence of care
Demographic
Characteristics

Total

Qualified for Follow
Up1
n=467
n
%

N=1019
n
%
Age (years)
18 to 24
25 to 34
35 to 44
45 to 54
55 or older
Sex
Male
Female
Race
Black
White
Other
Ethnicity
Non-Hispanic
Hispanic
Referral Source
Provider
DIS/OOJ
Surveillance

Age (years)
Time since HIV
diagnosis (years)
Most recent CD4 count
(cells/µL)
Most recent Viral Load
(copies/mL)

Evidence of Care2
n=552
n

%

77
259
273
261
149

7.6
25.4
26.8
25.6
14.6

39
131
131
107
59

8.4
28.1
28.1
22.9
12.6

38
128
142
154
90

6.9
23.2
25.7
27.9
16.3

752
267

73.8
26.2

349
118

74.7
25.3

403
149

73.0
27.0

601
401
17

59.0
39.4
1.7

281
177
9

60.2
37.9
1.9

320
224
8

58.0
40.6
1.5

776
243

76.2
23.9

353
114

75.6
24.4

423
129

76.6
23.4

586
71
362

57.5
35.5
7.0

236
52
179

50.5
11.1
38.3

350
19
183

63.4
33.2
3.4

Mean

[SD]

Mean

[SD]

Mean

[SD]

41.2
9.6

+11.7
+6.7

40.1
8.9

+11.8
+6.3

42.1
10.3

+11.7
+6.9

473.0

+362.8

462.4

+397.6

481.6

+332.1

53838.7

+397145.8

45540.6

+150437.6

60525.9

+516461.1

1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes
referral to the SL Program for further case investigation. For non -intervention subjects, follow up includes an additional surveillance
investigation 90 days after the initial record search date.
2. Referrals had evidence of care within the previous six months of initial surveillance investigation if there was a medical record appointment
and/or CD4+ T-lymphocyte count and/or viral load laboratory result within this timeframe and were not sent for follow up.

Low cell counts for the category of no reported CD4+ T-lymphocyte count resulted in
recategorization of this group to the referent. This action might bias results towards the null.
However, this decision also reflects the scenario where it might be assumed if this person lacks
51

evidence of laboratory tests, a proxy for steady care and monitoring adherence to ART treatment,
then, as best represented by accessible records, they might be at risk of lower CD4+ Tlymphocyte counts.
Table 15. Subgroups – breakdown of participant characteristics into clinical categories
for select independent variables
Demographic
Characteristics

Total
N=1019
n

Most recent CD4 counta
>200 cells/µL
<200 cells/µL
Most recent Viral Loadb
>200 copies/mL
<200 copies/mL
None reported

%

Qualified for Follow
Up1
n=467
n
%

Evidence of Care2
n=552
n

%

812
207

79.7
20.3

371
96

79.4
20.6

441
111

79.9
20.1

451
535
33

44.3
52.5
3.2

231
209
27

49.5
44.8
5.9

220
326
6

39.9
59.1
1.1

1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes
referral to the SL Program for further case investigation. For non -intervention subjects, follow up includes an additional surveillance
investigation 90 days after the initial record search date.
2. Referrals had evidence of care within the previous six months of initial surveillance investigation if there was a medical record appointment
and/or CD4+ T-lymphocyte count and/or viral load laboratory result within this timeframe and were not sent for follow up.
a
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever
having had a CD4+ T-lymphocyte count reported was recategorized to the referent group of >200 cells/µL due to cell counts less than 5.

Table 16. Significant factors associated with having recent evidence of care as the reason
for not qualifying for referral to the SL Program (N=1019) based on univariable analyses
Characteristic
Time since HIV diagnosis (years)
Referral Source
Most recent Viral Loada
a

χ2

β (SE)

P-value

N/A
30.6829
32.3537

0.0318 (0.00964)
N/A
N/A

0.0010
<.0001
<.0001

Most recent Viral Load is the most recent viral load laboratory result categorized as > 200 copies/mL or <200 copies/mL or no evidence of ever
having had a viral load laboratory result.

Age was significant in univariable analyses (continuous: β=0.0142, SE=0.00541, Pvalue=0.0088; categorical: χ2 =8.3722, P-value=0.0789) but dropped in the multiple logistic
regression model due to the significance and retention of time since HIV diagnosis (see
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correlation diagnostics post Table 12). Other significant variables identified in the simple
analyses included referral source and most recent viral load laboratory result; these variables
were retained in the multiple logistic regression model. All other factors were insignificant (Pvalue>0.25).
Table 17. Factors associated with having recent evidence of care as the reason for not
qualifying for referral to the SL Program (N=1019) based on multiple logistic regression
Characteristic
Time since HIV diagnosis (years)
Referral Source
Provider
DIS/OOJ
Surveillance
Most recent Viral Loadb
<200 copies/mL
>200 copies/mL
No report

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

1.029

1.009,1.049

0.0048

referent
0.376
0.624

Referent
0.203,0.696
0.476,0.819

referent
0.0019
0.0007

referent
0.640
0.158

Referent
0.494,0.831
0.044,0.572

referent
0.0008
0.0049

There were 10 observations deleted due to missing values for the response or explanatory
variables. Post-investigation revealed these missing observations were from the explanatory
variable time since HIV diagnosis.
Results suggest surveillance referral source (DIS/OOJ: β=-0.9787, SE=0.3145, Pvalue=0.0019; Surveillance: β=-0.4715, SE=0.1385, P-value=0.0007), having an unsuppressed
viral load at last report (β=-0.4456, SE=0.1328, P-value=0.0008) or no viral load reported (β=1.8455, SE=0.6562, P-value=0.0049), and time since HIV diagnosis (β=0.3709, SE=0.1440, Pvalue=0.0100) are significantly associated with having recent evidence of care (i.e., not being
currently out of care and needing follow-up services). Persons originating from the DIS or OOJ
list had 0.4 odds of having recent evidence of care and persons originating from the surveillance
list 0.6 odds of having recent evidence of care compared to persons referred to the program by
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providers. Furthermore, persons with unsuppressed viral loads or no reported viral loads had less
odds of recent evidence of care and were more likely to be confirmed as presumably out of care
and sent for follow up. Persons longer diagnosed with HIV infection had greater odds of having
recent evidence of care.
Since verification of a referrals’ current care status is difficult and time consuming, more
information is needed about the specific value of each laboratory and/or care data systems for
producing this vital information, especially since the most diverse and comprehensive access to
these records is housed by Health Departments. HEDSS/Maven and eHARS contributed CD4+
T-lymphocyte count and viral load laboratory results while CPCDMS and Epic provided HIVcare appointment dates. Evidence of care within the previous six months was found for 465
(84.2%) referrals in eHARS, 83 (15.0%) referrals in HEDSS/Maven, 100 (18.1%) referrals in
Epic, and 172 (31.1%) referrals in CPCDMS. The average number of days between the most
recent date for evidence of care and date of surveillance investigation was 142.4 (+134.8) for
eHARS, 70.3 (+51.5) for Maven, 59.7 (+46.2) for Epic, and 76.8 (+55.6) for CPCDMS.
Evidence of care could be found in multiple data systems within the same timeframe,
with either matching or varied dates. For instance, a person could attend a medical appointment
twice in the same timeframe as captured by Epic and CPCDMS and/or had laboratory tests
ordered for either of those appointments as reported to eHARS. Evidence of care was found
exclusively in a single data system for 348 (63.0%) referrals, among two data systems for 150
(27.2%) referrals, among three data systems for 44 (8.0%) referrals, and among four data
systems for 10 (1.8%) of referrals. For eHARS, evidence of care was found exclusively in this
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database for 283 referrals, exclusively in Maven for 9, exclusively in Epic for 16, and
exclusively in CPCDMS for 40.
Results for Aim 2
A total of 467 subjects qualified for follow up after initial surveillance investigation
given their lack of recent evidence of care. They could have originated from any of the original
data sources for potentially out-of-care persons, e.g., surveillance, provider, and DIS/OOJ (see
Study Subjects). However, a portion of the surveillance subjects were randomized as a nonintervention subgroup; therefore, while they could qualify for 90-day follow up, they could not
be referred to the SL Program. Consequently, of the 467 referrals qualifying for follow up, only
381 (81.6%) were sent to the SL Program for SLW assistance with returning to care. Subsequent
analyses focus on assessing the yield of the SL Program.
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Table 18. Participant characteristics of SL Program referrals and by SLW outcome
Demographic
Characteristics

Relinked to Care1

Total
N=381

Age (years)
18-34
35-44
45 or older
Sex
Male
Female
Race
Black/Other
White
Ethnicity
Non-Hispanic
Hispanic
Referral Source
Provider
DIS/OOJ
Surveillance
Client Phone Calls
Two or fewer
Three to six
Seven or more
Client Field Visits
Zero
One
Two
Three or more
Provider Phone Calls
Zero
One
Two or more
Provider Field Visits
Zero
One or more

Age (years)
Time since HIV diagnosis
(years)
Most recent CD4 count
(cells/µL)
Most recent Viral Load
(copies/mL)

n=31
n

Other Outcome2

%

n=350
n

n

%

%

147
100
134

38.6
26.3
35.2

12
8
11

38.7
25.8
35.5

135
92
123

38.6
26.3
35.1

282
99

74.0
26.0

25
6

80.7
19.4

257
93

73.4
26.6

248
133

65.1
34.9

25
6

80.7
19.4

223
127

63.7
36.3

292
89

76.6
23.4

25
6

80.7
19.4

267
83

76.3
23.7

236
52
93

61.9
13.7
24.4

10
13
8

32.3
41.9
25.8

226
39
85

64.6
11.1
24.3

94
150
137

24.7
39.4
36.0

5
8
18

16.1
25.8
58.1

89
142
119

25.4
40.6
34.0

102
86
108
85

26.8
22.6
28.4
22.3

5
8
9
9

16.1
25.8
29.0
29.0

97
78
99
76

27.7
22.3
28.3
21.7

342
15
24

89.8
3.94
6.30

5
10
16

16.1
32.3
51.6

337
5
8

96.3
1.4
2.3

344
37

90.3
9.7

---

---

---

---

Mean

[SD]

Mean

[SD]

Mean

[SD]

39.6
8.7

+11.9
+6.4

39.3
8.2

+13.1
+4.7

39.6
8.8

+11.8
+6.5

453.0

+414.8

410.8

+322.5

456.1

+421.1

46980.1

+156607.5

134940.8

+348622.6

40028.8

+128626.3

1. SLW clients were relinked to care if they attended a medical appointment.
2. Other outcomes include incarcerated, deceased, (self-reported) already in care, out of jurisdiction, refused (SL Program services), and other.
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible.
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Client sent to the SL Program were, on average, aged 40 years old, had been diagnosed
with HIV for about 9 years, and were majority male, black/other race, and non-Hispanic. The
original category of ‘other race’ was recategorized to ‘black’ due to too few counts, and this
classification was chosen to represent persons of color.
Table 19. Subgroups – breakdown of participant characteristics into clinical categories
for select independent variables
Demographic
Characteristics

N=381
n
Most recent CD4 count
>200 cells/µL
<200 cells/µL
None reported
Most recent Viral Load
>200 copies/mL
<200 copies/mL
None reported

Relinked to Care 1

Total

%

n=31
n

Other Outcome2

%

n=350
n

%

276
83
22

72.4
21.8
5.8

15
10
6

48.4
32.3
19.4

261
73
16

74.6
20.9
4.6

195
160
26

51.2
42.0
6.8

15
11
5

48.4
35.5
16.1

180
149
21

51.4
42.6
6.0

1. SLW clients were relinked to care if they attended a medical appointment.
2. Other outcomes include incarcerated, deceased, (self-reported) already in care, out of jurisdiction, refused (SL Program services), and other.

Of the 381 persons referred to the SL Program, 31 (8.1%) were relinked to care, 193
(50.7%) were located but had another disposition, and 157 (41.2%) were unable to locate. Of the
193 located with an ‘other’ disposition, these dispositions were: 11 (5.7%) deceased, 9 (4.7%)
incarcerated, 59 (30.6%) located and refused SLW services, 90 (46.6%) located and already in
care, 18 (9.3%) out of jurisdiction, and 6 (3.1%) other (e.g. client claims stolen identity, false
positive/HIV-negative, mental or physically incapacitated due to other health conditions).
Locating clients who have been out of care is a laborious task. Every available phone
number sent to the SLW was supposed to be called a minimum of two times, and, if the client
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could not be reached via phone, a field visit should have been made at least one time to each of
the addresses provided during surveillance investigation, and a certified letter was left at the
residence if no one was available to speak to the SLW regarding the client of interest. The two
most recent addresses for the client were collected during the initial record searches if there were
at least two addresses linked to the referral. Occasionally, although rare, a client might not have
any phone numbers available, and a SLW might only be able to make field visits in their
attempts to find the client during outreach.
For those referrals sent to an SLW, per client, the SLWs made zero phone calls 7 times,
one phone call 50 times, two phone calls 37 times, three to four phone calls 87 times, five to six
phone calls 63 times, seven to eight phone calls 48 times, and nine or more phone calls 89 times.
For the same set of referrals, per client, the SLWs made zero field visits 102 times, one field visit
86 times, two field visits 108 times, three field visits 52 times, four field visits 21 times, and five
more field visits 12 times.
Provider phone calls and visits could occur at multiple points of SLW outreach to the
client. Examples include confirming a self-reported outcome of “already in care” where, if a
specific provider was named, an SLW would attempt to follow up with that provider to confirm
the care status. During patient chart construction to determine eligibility for Ryan White
services, laboratory results are needed (e.g., to confirm diagnosis), and an SLW might need to
contact a provider to obtain this information on behalf of a client to alleviate the client’s burden
of having to obtain more paperwork themselves. Furthermore, an SLW will assist the client by
attending the first medical appointment with them during relinkage to care to ensure remaining
paperwork is completed as easily as possible, help communicate the process between the
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network and the client, and provide any other resources as necessary. For those referrals sent to
an SLW, per client, the SLWs made zero phone calls 336 times, one phone call 15 times, two to
four phone calls 19 times, and five or more phone calls 5 times to the provider(s). For the same
set of referrals, per client, the SLWs made zero field visits 344 times, one field visit 9 times, two
field visits 13 times, three field visits 6 times, and four or more field visits 9 times to the
provider(s).
Table 20. Self-reported reasons for falling out of care for those successfully contacted by
SLWs
Self-Reported Reasons for Being Out of Care
Unknown – no show at scheduled intake/medical appointments
Unknown – refused to disclose to SLW
Feels good/was healthy at last doctor appointment
Claims to already be in care but no provider reported
Unfriendly care setting
Does not want/need HHD services
SLW lost contact *
Does not believe HIV test results
Reportedly has private/other insurance, no supplemental services needed
Lives out of the United States and is provided care out of the United States
Only ancillary services requested
Relinked to care on their own without SLW assistance
Lack of support (e.g., economic, medical, social, mental, etc.)
Cost of HIV Care
Other life issues more important
Believes they do not qualify for assistance/services
Moved out of the jurisdiction and established care
Other life issues more important
Wait times (to schedule an appointment)
Financial Difficulties
Work Schedule
Does not want to take medication
Does not want to register every year for (Ryan White) eligibility
Wants holistic medicine/alternative treatments

Total
31
24
9
7
6
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1

Note1. Results are not mutually exclusive.
*. Includes but is not limited to working/established phone number disconnected, client moved and provided no viable forwarding address, client
stopped returning phone calls and/or responding to additional follow up attempts, etc.

Of the 224 clients with some sort of successful contact and/or relinkage to care, an
attempt was made to determine their reasons for falling out of care. Clients could report multiple
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reasons, totaling 3 per person, therefore Table 20 does not represent mutually exclusive results.
Most persons were out of care for unknown reasons and were subsequently lost to relinkage
attempts when they failed to attend their intake or medical appointment. The primary reason
reported to SLWs for being out of care is that the client feels good and/or reported they were in
good health at their last care appointment. The second reason was the clients reported being
already in care although they failed to report evidence of a current provider and/or recent
appointment followed by a third reason of they did not believe they needed HHD services. The
remaining reasons for having fallen out of care are diverse and seemingly unique to the situation
of the individual.
Table 21. Significant factors associated with being successfully relinked to care by an
SLW (N=381) from univariable analyses
Characteristic
Race
Referral Source
Most recent CD4 count
Most recent Viral Load
Client Phone Calls
Provider Phone Calls
Provider Field Visits
a

χ2

P-value

3.5926
24.6117
15.1729
4.6736
7.1614
N/A
N/A

0.0580
<.0001
0.0005
0.0966
0.0279
<.0001a
<.0001a

. Fisher’s exact test.

Two independent variables, provider phone calls, dichotomized as 0 vs 1 or more, and
provider field visits, dichotomized as 0 vs 1 or more, were significantly associated with the
relinkage outcome variable during univariable analyses using Fisher’s exact test (P-value<.0001)
but were dropped from the final multivariable model due to numerical instability. Observed
and/or expected cell counts for some cells were at or close to 0 despite recategorizing to the
lowest possible level, creating large variations between groups in a small sample size. Variables
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of significance (P-value<0.25) in simple analyses and retained in the multiple logistic regression
model include race, referral source, most recent CD4 count, most recent viral load laboratory
result, and client phone calls. All other variables were insignificant (P-value>0.25).
Table 22. Factors associated with being successfully relinked to care by an SLW
(N=381) from multiple logistic regression
Characteristic
Race
White
Black/Other
Referral Source
Provider
DIS/OOJ
Surveillance
Most recent CD4 count
>200 cells/µL
<200 cells/µL
None reported
Client Phone Calls
Two or fewer
Three to six
Seven or more

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

referent
1.974

referent
0.822,5.381

referent
0.1436

referent
7.242
2.722

referent
2.603,20.343
1.011,7.186

referent
0.0001
0.0396

referent
2.347
2.768

referent
0.965,5.512
0.726,10.234

referent
0.0508
0.1324

referent
1.571
3.879

referent
0.487,5.586
1.359,12.770

referent
0.4541
0.0143

There were no observations deleted due to missing values for the response or explanatory
variables.
Most recent viral load result was eliminated from the final model upon backwards
selection. DIS/OOJ referral source was associated with successful relinkage to care (β=1.9799,
SE=0.5175, P-value=0.0001) as was surveillance referral source (β=1.0015, SE=0.4865, Pvalue=0.0396). A last reported CD4+ T-lymphocyte count of less than 200 cells/µL was
borderline significant (β=0.98530, SE=0.4366, P-value=0.0508), while a total of seven or more
phone calls to the client by the SLW (β=1.3556, SE=0.5536, P-value=0.0143) was significantly
related to returning to care. It is interesting to note that a high number of phone calls (>7 times)
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per client was significantly related with relinkage to care, but the middle range of three to six
was not. An SLW is required to attempt each phone number available per client a minimum of
two times until they reach the client and/or the phone number is disconnected, then they stop.
For example, if a client has 4 numbers, an SLW would make a minimum of 8 attempts to
reach that person if none of the outreaches are successful. Clients called seven or more times
had more than 3 times the odds of successful relinkage to care. Persons from the DIS/OOJ
referral source had an almost 8 times greater odds of being relinked to care than those from the
provider source, while persons from the surveillance list had almost 3 times greater odds
compared to those from the provider source.
There was an average of 69.7 (+95.5) days from the date of receipt by the SL Program to
the intake date with an SLW. There was an average of 24.0 (+18.1) days from the intake with an
SLW to the first medical appointment.
An exploratory analysis was conducted to determine if there were any significant
associations with being located by an SLW if persons qualified for the SL Program. Persons lost
to care are difficult to find due to sometimes substantial lengths of time missing from the medical
system and/or sparse locating information, despite extensive surveillance investigation prior to
referral. Determining if the time and resources spent by the SLWs in their attempts to contact
these persons is fruitful and/or whether other characteristics might yield higher response could
assess best practices moving forward.
Being successfully located was defined as at least one incident of verbal and/or physical
contact via phone and/or field visit by an SLW with the persons of interest. Identity is confirmed
by the SLW via date of birth and legal name. Other documentation might also be used.
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Table 23. Participant characteristics of SL Program referrals and by SLW outreach
attempt outcome
Demographic
Characteristics
Age (years)
18 to 24
25 to 34
35 to 44
45 to 54
55 or older
Sex
Male
Female
Race
Black/Other
White
Ethnicity
Non-Hispanic
Hispanic
Referral Source
Provider
DIS/OOJ
Surveillance
Client Phone Calls
Two or fewer
Three to six
Seven or more
Client Field Visits
Zero
One
Two
Three or more
Provider Phone Calls
Zero
One or more
Provider Field Visits
Zero
One or more
Age (years)
Time since HIV diagnosis
(years)
Most recent CD4 count
(cells/µL)
Most recent Viral Load
(copies/mL)

Total
N=381

Located by SLW1
n=224
n
%

Unable to Locate2
n=157
n
%

n

%

37
110
100
88
46

9.7
28.9
26.3
23.1
12.1

20
63
48
58
35

8.9
28.1
21.4
25.9
15.6

17
47
52
30
11

10.8
29.9
33.1
19.1
7.0

282
99

74.0
26.0

169
55

75.5
24.6

113
44

72.0
28.0

248
133

65.1
34.9

149
75

66.5
33.5

99
58

63.1
36.9

292
89

76.6
23.4

175
49

78.1
21.9

117
40

74.5
25.5

236
52
93

62.0
13.7
24.4

127
40
57

56.7
17.9
25.5

109
12
36

69.4
7.6
22.9

94
150
137

24.7
39.4
36.0

64
87
73

28.6
38.8
32.6

30
63
64

19.1
40.1
40.8

102
86
108
85

26.8
22.6
28.4
22.3

--43
29

--19.2
13.0

--65
56

--41.4
35.7

342
39

89.8
10.2

---

---

---

---

344
37
Mean
39.6
8.7

90.3
9.7
[SD]
11.9
6.4

--Mean
9.3
40.8

--[SD]
6.7
12.5

--Mean
37.9
8.0

--[SD]
10.8
5.8

453.0

414.8

440.9

291.8

468.8

536.0

46980.1

156608.0

42394.3

147117.6

53104.6

168754.7

1. Successfully located was defined as at least one incident of verbal and/or physical contact via phone and/or field visit by a n SLW with the
persons of interest.
2. Unable to locate includes client could not be contacted via phone and/or field visit (e.g., no response).
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible.
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Table 24. Subgroups – breakdown of participant characteristics into clinical categories
for select independent variables

Demographic
Characteristics

N=381
n
Most recent CD4 counta
>200 cells/µL
<200 cells/µL
Most recent Viral Loadb
>200 copies/mL
<200 copies/mL

Located by SLW1

Total

%

n=224
n

Other Outcome2

%

n=157
n

%

298
83

78.2
21.8

175
49

78.1
21.9

123
34

78.3
21.7

195
186

51.2
48.8

100
124

44.6
55.4

95
62

60.5
39.5

1. Successfully located was defined as at least one incident of verbal and/or physical contact via phone and/or field visit by a n SLW with the
persons of interest.
2. Unable to located includes client could not be contacted via phone and/or field visit (e.g., no response).
a
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL.
b
Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/m L.

Table 25. Significant factors associated with being located by an SLW (N=381) from
univariable analyses
χ2

β (SE)

P-value

9.7099
5.1048
96.5158
N/A
N/A
9.3003
N/A

N/A
N/A
N/A
N/A
N/A
N/A
0.0338

0.0078
0.0779
<.0001
<.0001a
<.0001a
0.0023
0.0474

Characteristic
Referral Source
Client Phone Calls
Client Field Visits
Provider Phone Calls
Provider Field Visits
Most recent Viral Load Resultb
Time since HIV Diagnosis (years)
b

a
. Fisher’s exact test.
Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever
having had a viral load laboratory result was recategorized to the referent group of >200 copies/mL due to small cell sizes.

Two independent variables, provider phone calls, dichotomized as 0 vs 1 or more, and
provider field visits, dichotomized as 0 vs 1 or more, were significantly associated with the
relinkage outcome variable during univariable analyses using Fisher’s exact test (P-value<.0001)
but were dropped from the final multivariable model due to numerical instability. Observed
and/or expected cell counts for some cells were at or close to 0 despite recategorizing to the
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lowest possible level, creating large variations between groups in a small sample size and
numerical instability. Age was significant in univariable analyses (continuous: β=0.0216,
SE=0.00901, P-value=0.0165; categorical: χ2 =12.7742, P-value=0.0124) but dropped in the
multivariable model due to the significance and retention of time since HIV diagnosis.

Table 26. Factors associated with being located by an SLW (N=381) based on multiple
logistic regression.
Characteristic
Time since HIV Diagnosis (years)
Referral Source
Provider
DIS/OOJ
Surveillance
Most recent Viral Load
<200 copies/mL
>200 copies/mL
Client Phone Calls
Two or fewer
Three to six
Seven or more
Client Field Visits
Zero
One
Two
Three or more

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

1.029

0.988,1.074

0.1707

referent
3.489
1.356

referent
1.609,7.919
0.753,2.449

referent
0.0023
0.3140

referent
0.587

referent
0.355,0.967

referent
0.0386

referent
1.634
2.341

referent
0.808,3.381
1.130,5.003

referent
0.1794
0.0255

referent
0.074
0.024
0.017

referent
0.022,0.195
0.007,0.065
0.005,0.048

referent
<.0001
<.0001
<.0001

There were 10 observations deleted due to missing values for the response or explanatory
variables. Post-investigation revealed these missing observations were from the explanatory
variable time since HIV diagnosis.
DIS/OOJ referral source was significantly associated with locating the client (β=1.2497,
SE=0.4098, P-value=0.0023), as was having a recent viral load laboratory result last reported as
>200 copies/mL (β=-0.5320, SE=0.2572, P-value=0.0386), calling the client seven or more
times (β=0.8506, SE=0.3809, P-value=0.0255), and making incrementally higher number of
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field visits to the client’s addresses (one: β=-2.6091, SE=0.5399, P-value=<.0001; two: β=3.7123, SE=0.5417, P-value=<.0001; three or more: β=-4.0468, SE=0.5645, P-value=<.0001).
DIS/OOJ referrals had 3.5 greater odds of being located by an SLW than provider referrals, and
clients contacted seven or more times via phone by an SLW had 2.3 greater odds of being
located than those contacted two or fewer times. In comparison, persons with a last reported
viral load that was unsuppressed or any number of field visits from an SLW had lower odds of
being successfully reached by an SLW.
Results for Aim 3
A subgroup of the population was randomized as intervention (n=200) and nonintervention subjects (n=200) from the surveillance data source (see Study Subjects).
Intervention participants were referred to the SL Program if record searches determined they did
not have recent evidence of care nor any other disposition. Non-intervention participants were
assigned for surveillance investigation follow up 90 days later if the first record search
determined they did not have recent evidence of care nor any other disposition. Priority
population information was only reported for these subjects given its original data source, the
surveillance list (i.e., eHARS), contains an existing field with this information. However, this
field is sparsely populated (unrecorded: n=332) with preset indicators chosen by the National
HIV/AIDS Strategy and adapted by the CDC.52,53 This information was excluded from tables
and analyses given the lack of data, but overall information is provided here to better represent
the population.
Of the total randomized population (n=400), 5 (1.3%) were transgender persons, all
identifying as male-to-female (birth sex male), 9 (2.3%) were young (i.e., 13-24 years old, as
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preset by the data system, although all participants in this study were aged 18+) and black, 54
(13.5%) were injection drug users (IDU), and 332 (83.0%) were unrecorded. For the IDU group,
among non-intervention subjects, 13 qualified for follow up and 14 did not qualify for follow up;
among intervention subjects, 14 qualified for follow up and 13 did not qualify for follow up. For
the same priority population, IDU, of those who qualified for follow up among non-intervention
subjects, 3 returned to care and 10 remained out of care; of those who qualified for follow up
among intervention subjects, 0 were relinked to care and 14 remained out of care. All other
priority populations reported were too few counts. Unrecorded was not included.
The randomized subgroup was aged 44 years on average with 11 years as the mean time
since HIV diagnosis and majority male, black, and non-Hispanic. Greater than half of all
randomized subjects had CD4+ T-lymphocyte counts >200 cells/µL and viral load results <200
copies/mL at last report.
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Table 27. Participant characteristics of randomized intervention and non-intervention subjects overall and by initial
surveillance investigation outcome (N=400)
Demographic
Characteristics

Intervention Group
N=200
Age (years)
18 to 34
35 to 44
45 to 54
55 or older
Sex
Male
Female
Race
Black/Other
Race
White
Ethnicity
Non-Hispanic
Hispanic
Age (years)
Time since HIV
diagnosis (years)
Most recent CD4
count (cells/µL)
Most recent Viral
Load (copies/mL)

Qualified for Follow Up1

Total
Non-Intervention
Group
N=200
n
%

n

%

47
58
60
35

23.5
29.0
30.0
17.5

42
63
55
40

156
44

78.0
22.0

113

Intervention Group
n=93

Other Outcome2

Non-Intervention
Group
n=86
n
%

n

%

21.0
31.5
27.5
20.0

17
31
30
15

18.3
33.3
32.3
16.1

23
31
19
13

151
49

75.5
24.5

73
20

78.5
21.5

56.5

97

48.5

58

87

43.5

103

51.5

159
41
Mean
43.9
10.5

79.5
20.5
[SD]
+11.2
+6.3

145
55
Mean
44.2
11.1

473.9

+324.6

75918.8

+411051.6

Intervention Group
n=107

Non-Intervention
Group
n=114
n
%

n

%

26.7
36.1
22.1
15.1

30
27
30
20

28.0
25.2
28.0
18.7

19
32
36
27

16.7
28.1
31.6
23.7

67
19

77.9
22.1

83
24

77.6
22.4

84
30

73.7
26.3

62.4

42

48.8

55

51.4

55

48.3

35

37.6

44

51.2

52

48.6

59

51.8

72.50
27.50
[SD]
+11.0
+6.5

74
19
Mean
43.8
9.8

79.6
20.4
[SD]
10.2
6.3

61
25
Mean
42.3
9.5

70.9
29.1
[SD]
+10.9
+6.1

85
22
Mean
43.9
11.1

79.4
20.6
[SD]
12.0
6.3

84
30
Mean
45.6
12.3

73.7
26.3
[SD]
+10.9
+6.5

467.1

+277.6

448.2

257.8

502.1

+313.7

496.3

372.9

441.0

+245.6

32641.4

+113130.9

74203.1

253722.8

39528.4

+121949.9

77394.0

510235.8

27460.9

+106277.6

1. Intervention and non-intervention subjects were assigned for follow up because they lacked any evidence of recent care and/or other outcome so were presumed to be currently out-of-care. For
intervention subjects, follow up entailed assignment to the SL Program for SLW assistance with returning to care. For the non-intervention subjects, follow up entailed an additional surveillance
investigation (i.e., record search) 90 days after the initial record search date.
2. ‘Other Outcomes’ for intervention and non-intervention subjects were identical and include: incarcerated, deceased, evidence of care, out of jurisdiction, and ineligib le. ‘Other Outcomes’ originated
from the first surveillance investigation.
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Table 28. Subgroups – breakdown of randomized intervention and non-intervention participant characteristics into clinical
categories for select independent variables (N=400)
Demographic Characteristics
Intervention
Subgroup
N=200
n
%
Most recent CD4 counta
>200 cells/µL
<200 cells/µL
Most recent Viral Loadb
>200 copies/mL
<200 copies/mL

Qualified for Follow Up1

Total
Non-Intervention
Subgroup
N=200
n
%

Intervention
Subgroup
n=93
n
%

Other Outcome2

Non-Intervention
Subgroup
n=86
n
%

Intervention
Subgroup
n=107
n
%

Non-Intervention
Subgroup
n=114
n
%

156
44

78.0
22.0

168
32

84.0
16.0

73
20

78.5
21.5

73
13

84.9
15.1

83
24

77.6
22.4

95
19

83.3
16.7

80
120

40.0
60.0

74
126

37.0
63.0

37
56

39.8
60.2

35
51

40.7
59.3

64
43

59.8
40.2

39
75

34.2
65.8

1. Intervention and non-intervention subjects were assigned for follow up because they lacked any evidence of recent care and/or other outcome so were presumed to be currently out-of-care. For
intervention subjects, follow up entailed assignment to the SL Program for SLW assistance with returning to care. For the non-intervention subjects, follow up entailed an additional surveillance
investigation (i.e., record search) 90 days after the initial record search date.
2. ‘Other Outcomes’ for intervention and non-intervention subjects were identical and include: incarcerated, deceased, evidence of care, out of jurisdiction, and ineligib le. ‘Other Outcomes’ originated
from the first surveillance investigation.
a
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever having had a CD4+ T-lymphocyte count reported was
recategorized to the referent group of >200 cells/µL due to cell counts less than 5.
b
Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever having had a viral load laboratory result was
recategorized to the referent group of >200 copies/m L due to small cell sizes.
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Of the 200 non-intervention subjects, 114 (57.0%) received an initial record search
disposition. Of these, primary surveillance investigation found 2 (1.75%) persons were
incarcerated, 1 (0.88%) was deceased, 92 (80.7%) had recent evidence of care, and 19 (16.7%)
were out of jurisdiction. A remaining 86 (43%) qualified for 90-day follow up without SLW
intervention. The second surveillance investigation after the 90-day follow up period found that
15 (17.4%) had evidence of care, i.e., had returned to care, while 4 (4.7%) were out of
jurisdiction and 67 (77.9%) had no evidence of care or any other outcome and were presumed to
still be out of care within the Houston/Harris County area. Within the 90-day follow-up period,
the mean number of days for the non-intervention subjects to return to care was 45.9 (+31.7).
Of the 200 intervention subjects, initial surveillance investigation produced 107 (53.5%)
dispositions. Of these, 2 (1.9%) were deceased, 14 (13.1%) were out of jurisdiction, and 91
(85.1%) had recent evidence of care. Ninety-three (46.5%) individuals qualified for follow up
and were referred to the SL Program. Of these, 8 (8.6%) were relinked to care; remaining
dispositions were 1 (1.1%) deceased, 2 (2.2%) incarcerated, 34 (36.6%) already in care, 2 (2.3%)
located out of jurisdiction, 35 (37.6%) were unable to locate, and 11 (11.8%) were located but
refused SLW services. The mean number of days for intervention subjects to be relinked to care
from the intake date with an SLW was 12.0 (+11.0).
A comparison of the subjects randomized into the intervention group (n=200) and nonintervention group (n=200) from the same referral source (e.g., surveillance list) indicated no
differences existed between the samples (P-value>0.05).
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Table 29. Participant characteristics of randomized intervention and non-intervention subjects assigned for follow up and by
follow-up outcome (N=179)
Demographic
Characteristics
Intervention
Subgroup
N=93
n
%
Age (years)
<45
>45
Sex
Male
Female
Race
Black/Other
White
Ethnicity
Non-Hispanic
Hispanic

Age (years)
Time since HIV
diagnosis (years)
Most recent CD4
count (cells/µL)
Most recent Viral
Load (copies/mL)

Returned to Care1

Total
Non-Intervention
Subgroup
N=86
n
%

Intervention
Subgroup
n=8
n
%

Other Outcome2

Non-Intervention
Subgroup
n=15
n
%

Intervention
Subgroup
n=85
n
%

Non-Intervention
Subgroup
n=71
n
%

48
45

51.6
48.4

35
51

40.7
59.3

---

---

9
6

60.0
40.0

---

---

45
26

63.4
36.6

73
20

78.5
21.5

67
19

77.9
22.1

---

---

---

---

---

---

---

---

58
35

62.4
37.6

42
44

48.8
51.2

---

---

5
10

33.3
66.7

---

---

37
34

52.1
47.9

74
19

79.6
20.4

61
25

70.9
29.1

---

---

9
6

40.0
60.0

---

---

52
19

26.8
73.2

Mean

[SD]

Mean

[SD]

Mean

[SD]

Mean

[SD]

Mean

[SD]

Mean

[SD]

43.8
9.8

10.2
6.3

42.5
9.5

+10.9
+6.1

36.1
7.5

6.4
3.4

42.7
9.5

+11.7
+4.9

44.5
10.0

10.2
6.5

42.5
9.5

+10.8
+6.4

448.2

257.8

502.1

+313.7

450.8

410.1

472.9

+299.6

448.0

242.5

508.4

+318.4

74203.1

253722.8

39528.4

+121949.9

264147.3

549703.2

51325.3

+104360.1

56113.2

203191.9

37000.5

+125929.5

1. Intervention subjects returned to care if they were successfully relinked to medical care through SLW assistance. Non-intervention subjects returned to care if record searches during the second
surveillance investigation yielded a medical appointment and/or CD4+ T-lymphocyte count and/or viral load laboratory result during the 90-day follow up period.
2. ‘Other Outcomes’ for intervention subjects include: incarcerated, deceased, already in care, out of jurisd iction, refused services, unable to locate, and other. ‘Other Outcomes’ for non-intervention
subjects include: evidence of care, incarcerated, deceased, and out of jurisdiction.
*. Time in years, with smallest categorize absorbed into the next closet g roup.
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible.

71

Table 30. Subgroups – breakdown of randomized intervention and non-intervention participant characteristics into clinical
categories for select independent variables (N=179)
Demographic Characteristics

Intervention
Subgroup
N=93
n
Most recent CD4 counta
>200 cells/µL
<200 cells/µL
Most recent Viral Loadb
>200 copies/mL
<200 copies/mL

Returned to Care1

Total

%

NonIntervention
Subgroup
N=86
n
%

Other Outcome2

Intervention
Subgroup

NonIntervention

Intervention
Subgroup

n=8
n

n=15
n

n=85
n

%

%

%

NonIntervention
Subgroup
n=71
n
%

69
16

81.2
18.8

73
13

84.9
15.1

---

---

---

---

---

---

---

---

37
56

39.8
60.2

35
51

40.7
59.3

---

---

5
10

33.3
66.7

---

---

30
41

42.3
57.8

1. Intervention subjects returned to care if they were successfully relinked to medical care through SLW assistance. Non-intervention subjects returned to care if record searches during the second
surveillance investigation yielded a medical appointment and/or CD4+ T-lymphocyte count and/or viral load laboratory result during the 90-day follow up period.
2. ‘Other Outcomes’ for intervention subjects include: incarcerated, deceased, already in care, out of jurisdiction, refused services, unable to locate, and other. ‘Other Outcomes’ for non-intervention
subjects include: evidence of care, incarcerated, deceased, and out of jurisdiction.
a
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever having had a CD4+ T-lymphocyte count reported was
recategorized to the referent group of >200 cells/µL due to cell counts less than 5.
b
Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever having had a viral load laboratory result was
recategorized to the referent group of >200 copies/mL due to small cell sizes.
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To assess whether the SL Program impacts relinkage to care, analyses were performed to
determine if, among those persons qualifying for follow up (n=179) for the randomized group,
subjects were successfully relinked to care based on intervention group status.

Table 31. Significant factors associated with returning to care (N=179) from univariable
analyses
χ2

β (SE)

P-value

1.4815
1.7044
3.1179

N/A
N/A
N/A

0.2235
0.1917
0.0774

Characteristic
Ethnicity
Age (years)
Intervention Status

*. Age is categorical; 44 years or less vs 45 years or greater

Unlike previous analyses, the variable Age was significantly associated (P-value>0.25) in
univariable analyses and time since HIV diagnoses was not. Given these results, Age was
included in the final multiple logistic regression model since the correlation between Age and
time since HIV diagnosis was negated.

Table 32. Factors associated with returning to care (N=179) based on full multiple
logistic regression model.
Characteristic
Age (years)
44 or fewer
45 or greater
Ethnicity
Non-Hispanic
Hispanic
Intervention Status
Non-SLW
SLW

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

referent
0.636

referent
0.238,1.575

referent
0.3408

referent
1.560

referent
0.590,3.888

referent
0.3511

referent
0.504

referent
0.197,1.218

referent
0.1350

73

Results in the full multiple logistic regression model are provided in Table 32 prior to
backwards elimination. Based on a significance level of P-value<0.05, none of the variables
were significant predictors of the outcome prior to subsequent model fit evaluation. Ethnicity
was subsequently eliminated, with remaining significance values indicating further adjustment
was still needed (P-value>0.20), so Age was omitted. Therefore, the final model was log(p/(1p))=β0 + β1*Intervention Status. Although the Hosmer-Lemeshow test failed to reject the null
hypothesis for the full model, so there was no evidence for lack of fit, and a comparison of AIC
and R-square values suggests the full model (Table 32) is the best fit, there was minimal
variation between the AIC and R-square values across the full model, model with the elimination
of Ethnicity, and model with the elimination of Age (e.g., less than a 0.012 difference for Rsquare values between the highest and lowest; less than a 3.0 difference for AIC values between
the highest and lowest).
Given these results and to further inform the primary relationship of interest, backwards
elimination was still performed, leading to the eventual final model. The Hosmer-Lemeshow
test failed to produce a significant value as there was only one binary categorical predictor in this
model.
Table 33. Factors associated with returning to care (N=179) based on reduced multiple
logistic regression model.
Characteristic
Intervention Status
Non-SLW
SLW

Odds Ratio

Multiple Logistic Regression
95% CI

P-value

referent
0.459

referent
0.180,1.098

referent
0.0890
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Intervention Status was insignificant (β=-0.3898, SE=0.2292, P-value=.0890). Persons
randomized to an SLW were about half as likely to be relinked to care compared to those who
returned to care on their own without the intervention, although results were above the cutoff for
significance at P-value>0.05.
Figure 4. Description of probability of returning to care based on intervention status
(SLW vs. non-SLW) for persons randomized and qualifying for follow up (N=179)

Figure 4 is a visual representation of the relationship between the main independent
variable of interest, intervention status (e.g., assigned to an SLW vs. not assigned to an SLW
after qualifying for follow up post-surveillance investigation), and the outcome of interest (e.g.,
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returned to HIV care vs. not returned to HIV care). As depicted, persons not assigned to the SL
program had a slightly higher probability of returning to HIV care compared to those assigned to
the SL Program, although results were insignificant at an alpha of 0.05 (P-value=.0890).

Discussion
The majority of PLWH presumed to be out of care and referred to the HHD for record
search investigation failed to qualify for follow up. The primary reason was they had evidence
of care (67.3%) followed by out of jurisdiction (16.0%), validating the contribution health
departments can make in comprehensive health record knowledge while highlighting the
majority of presumptions about the out-of-care population are likely inflated. Despite
differences in methodologies, D2C programs using various surveillance and care investigat ions
to identify and locate presumed out-of-care persons have consistently learned greater than 50%
of all presumed lost-to-care persons failed to qualify for public health follow up, having been
found to be in recent care with other factors such as migration, death, and incarceration distorting
engagement- in-care estimates.18,19,21,32,54 Migration might be particularly characteristic in
Houston given its proximity to the Mexico border, as some people reported being in care but out
of country (.
Table 20).
DIS/incoming OOJ referrals, surveillance referrals, and having had an unsuppressed viral
load at last report were associated with greater odds of qualifying for follow up while persons
diagnosed with HIV longer had lower odds of qualifying for follow up. Although not equal
measures, age was eliminated from the statistical models because it was strongly correlated with
time since HIV diagnosis, and retaining time since HIV diagnosis contributed a unique measure
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which has been often overlooked in D2C programs. However, when one considers the
correlation with age, the significance of persons diagnosed with HIV for a longer period having
less odds of qualifying for follow up might reflect trends in the Houston EMA Care Continuum.
When broken down by age groups in 2016, ranging from 13-24, 25-34, 35-44, 45-54, to 55+,
retention in care and viral suppression increased sequentially across all groups. Literature
supports persons of older age being more likely to be virally suppressed with greater retention
and treatment adherence.55–58 Someone of older age might not be newly diagnosed, but given, as
someone both ages and lives longer with HIV, they might be more likely to face an increasing
number of health challenges, so they also might be more likely to seek out medical care and have
more motivation to stay in care. This possibility is reflected in .
Table 20, where some persons reported being out of care because they “feel good/was
healthy at last doctor appointment,” although this relationship might be extraneous. Future
studies might consider measuring the effects of the length of HIV diagnosis given the lack of
knowledge of this factor on relinkage to care. They might also consider a new variable factoring
in both measures of time since HIV diagnosis and year of birth.
DIS/incoming OOJ referrals had recent contact with PLWH, thereby making it more
likely that a person would be correctly identified, initially, as out of care and in the jurisdiction,
alive, and not incarcerated. One D2C study acknowledged an usually high rate of relinkage to
care at 71.2% for persons confirmed out of care, and this program employed expanded partner
services (ExPS) in lieu of service linkage workers. 59 Although their study population originated
solely from surveillance sources and served a markedly differently population, one which was
non-metropolitan and cross-county in upstate New York, all record-search investigations and
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patient outreach were conducted by ExPS-designated staff members, which might speak to an
alternative relinkage-to-care strategy worth exploring.
Provider referrals might benefit from additional outreach by program staff and/or
restrictive criteria for out-of-care persons. Providers reserve a specific scope of knowledge for
the patients they serve in that they are restricted to the electronic medical records (EMRs) under
their purview and authority, which might explain why clinic-based data has yielded potentially
out-of-care clients who have simply moved out of jurisdiction or to another care system.33
Nonetheless, providers are integral to the care-prevention foundation upon which D2C programs
rest, and other studies have taken more progressive steps towards provider
inclusivity.21,32,33,39,59,60 Within the Houston/Harris County program, the separation of HIV
prevention and care services by City and County governing bodies is a significant hurdle towards
similar approaches, but the foundational partnerships established in this study are a valued
achievement. These partnering providers often lack dedicated staff to identify and refer PLWH
to the HHD, and their systems might not be easily adaptable for this purpose, requiring
significant manual effort without outside assistance, support, or other allocated resources. The
mechanism for referral to the HHD was via paper, sometimes extracted by hand, making
prioritization of these lists for surveillance investigation difficult. Resource support for
providers and/or emphasizing more restrictive criteria might improve the quality of these lists
and relinkage to care outcomes. Additionally, the SL Program might leverage unique qualities of
providers, such as their ability to identify persons loosely engaged with care, marked by
repeatedly missed/canceled appointments or high viral loads despite antiretroviral treatment, and
open a new referral system for this at-risk population, although refinement of this definition
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might prove challenging.61 Capturing persons before they are lost to the system completely by
falling out of care would improve health outcomes for PLWH and assist each institution with
achieving programmatic goals.
One potential, immediate possibility for improved provider-health department relations is
the HHD’s prospective role in fulfilling necessary standards of care, an avenue worth exploring.
Ryan White Part A requires documentation of three attempts by more than one method to contact
clients, a critical component of medical case management. 26 Operating under respective regional
administrative codes and the guidance of state health authorities, health departments might be
able to alleviate this burden through D2C follow up by reporting aggregate or individually-based
outcomes to the original referring provider, a bilateral information exchange undertaken by other
D2C programs.21,32,39 Studies have demonstrated that reminder telephone calls reduce missed
appointments, but some clinics had difficulty following up with patients solely via this method
due to disconnected phones, with the percent disconnected as high as 50%. 62,63 The SL Program
can leverage greater locating data through surveillance investigation and larger outreach
resources beyond the telephone. This expanded partnership would strengthen services to the
HIV community and create more possibilities to understand persons at-risk and potentially most
receptive to targeted interventions such as described here.
Laboratory results from hospitals, if they were CD4+ T-lymphocyte count and/or viral
loads, counted as care for this study, but hospital networks are poor markers for health outcomes
given they are not a primary HIV medical home, yet they might provide an opportunity for HIVcare reengagement. Louisiana is a remarkable example of a bidirectional, public-health
information exchange leveraging the strengths of a state-wide, relinkage-to-care effort.
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Combining the best of two worlds, provider networks and active referrals, it was designed to
produce real-time provider alerts when PLWH lacking any CD4+ T-lymphocyte count/viral load
monitoring within the past 12 months seek non-HIV related care in their integrated delivery
network.64,65 This alert permits immediate relinkage to HIV specialty care. Within two years,
alerts were received across 60 clinics, 223 clinics, and 7 facilities for 419 out-of-care PLWH, of
which 76% were once in care previously, and 85% of those persons had at least one CD4+ Tlymphocyte count/viral load result during follow up.64,65 This program, implemented in a
Southern environment, suggests there is an opportunity to capture persons lost to care while they
are actively seeking medical treatment for other conditions, with elements potentially applicable
in the Houston area.
This study was distinct in its analysis of differences between persons qualifying for
follow up and those who had recent evidence of care, an attempt to understand if there were
certain characteristics associated with a critical measure of interest, the truly out-of-care
population. Associations were similar to the analyses among persons qualifying for follow up,
which was not unexpected given the majority of persons who did not qualify for follow up did so
because of recent evidence of care. The only newfound relationship was the significance of
persons with no viral load at last report having less odds of having recent evidence of care, which
might indicate that persons without these laboratory measures are more likely to abstain from
care. However, other factors could easily be influencing this measure as well, like faulty
reporting, none of which are known. Future analyses might implement multinomial logistic
regression to determine if there are differences across dispositions, should they exist.
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Results of this study support eHARS as the most comprehensive HIV care system for the
HHD, with 84.2% of evidence of care found in this database during surveillance investigation,
exclusively 63.0% of the time. Selecting potentially out-of-care persons from this source is
reasonable but likely needs adjustments in parameters as its major weakness is reporting lag-time
and lack of real-time participant selection. Buchacz and colleagues found about 25% of
originally presumed out-of-care persons extracted from eHARS had altered eligibility upon reinvestigation 12 months post-initiation date, emphasizing the impact of reporting delays. 21
Although the HHD continues to improve timeliness and efficiency of HIV-case reporting
through provider education, electronic laboratory reporting through expansion of HEDSS
(Maven), data system integration, and routine review of internal processes and protocols, delays
remain an issue.66,67 Future analyses can perform an assessment of eHARS surveillance referrals
using the laboratory specimen date and reporting date to determine if the difference in time
within the HHD system was potentially impactful. Careful consideration of the HHD’s usage
might entail the decree of some sort of buffer period to account for these delays, similar to the
original CDC recommendations to account for reporting delays when performing trend analyses
prior to significant advances in data management and bioinformatics.68 Despite the identification
of each data systems’ usefulness, acting alone and in conjunction, data system integration would
eliminate the labor costs of manual surveillance investigations and create more actionable
processes.69
The HHD might produce the surveillance list at increased intervals (e.g., biannually,
quarterly, etc.) to avoid data expiration. As the HHD has demonstrated, prioritization will
continue to be necessary because the number of potentially out-of-care persons will far exceed
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the manpower and resources available to public health institutions. Viral suppression and a low
CD4+ T-lymphocyte count might be one consideration for ranking priority referrals. Viral
suppression at last report was associated with qualifying for follow up services while having a
last reported CD4+ T-lymphocyte count <200 cells/µL was marginally associated with relinkage
to care. One study found patients were more likely to return to care on their own if they had a
suppressed viral load.70 Recent D2C demonstration projects reflect these results through
incorporation of CD4+ T-lymphocyte count and viral load laboratory results as part of their
eligibility criteria, emphasizing that persons with low CD4+ T-lymphocyte counts or
unsuppressed viral loads were prioritized or considered for inclusion.21,39 This inversely begs the
question of whether persons with suppressed viral loads and/or high CD4+ T-lymphocyte counts
at last report are possibly lower priority. The HHD cannot access AIDS Drug Assistance
Program records, meaning no data is available regarding prescription distribution, negating any
ability to assess its effect on care indicators. Others have noted that, although the absence of
care over a defined interval is the current standard of lost to care, patients without care >12
months are often found to be virally suppressed, indicating a portion of this population almost
certainly continues treatment of some manner.32 Access to prescription- level data could have led
to their initial omission from D2C programs, reducing the number of persons with recent
evidence of care via surveillance investigation or self-reported care to the SLWs, increasing the
sample size and reducing resource expenditure.
The relinkage to care program yield was low. Even after exhausting health department
data system resources (n=381, 35.1%), the majority of persons were still unable to locate (n=157,
41.2%) and few were relinked to care (n=31, 8.1%). Of those located (n=193), the majority self82

reported already being in care (n=90, 46.6%) or refused SLW services once located (n=59,
30.6%). Unable to locate and/or refusal of services also made it difficult to collect information
about the reasons for being out of care, although the top 5 reported reasons after unknown
included feels good/was health at last doctor appointment, unfriendly care setting, does not
want/need HHD services, does not believe HIV test results, has private/other insurance and does
not need ancillary services. Being a no show at scheduled intakes and/or medical appointments
remains a significant hurdle to collecting data from this population, requiring changes in
methodology or other alternatives to data collection. 70 A reciprocal but critical relationship
exists between a person’s engagement with other stages of the Care Continuum and being out of
care. In the 2011 Houston Needs Assessment, the most common reason for seeking an HIV
diagnostic test among PLWH was “feeling sick,”2 inverse to the third leading cause of being out
of care as reported in this study which was “feels good/was health at last doctor appointment.”
This result might be more common in Houston and highlights the discordant nature of care
delivery and inadequate public health messaging. Other studies have not replicated a perceived
lack of need for HIV care as an access barrier in a state with near universal healthcare delivery. 71
The 2011 Houston needs assessment and other jurisdictions have likewise documented
similar barriers to care as reiterated in .
Table 20, such as long wait times, difficulty making/keeping appointments, and problems
with paperwork.2,71 Notably, a D2C study in Seattle/King County and the Houston Area
Comprehensive HIV Prevention and Care Services Plan for 2012-2014 found substance abuse,
homelessness/lack of stable housing, and variations of does not want HIV medication/doctor to
be conspicuously high reasons for having fallen out of care. PLWH in Houston reported the two
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most needed core HIV services were primary care (94%) and case management (84%),
respectively, yet 93% stated primary care was accessible and 88% stated case management was
accessible, each within the top five accessible services. Considering a lack of case management
has been significantly associated with being out of care in some studies, as well as ancillaryspecific conditions such as mental health or substance abuse services, more local research is
needed.72 The diversity in answers and difficulty in reaching this population to begin with create
a significant and continuing gap in knowledge about HIV care accessibility, which might be
confined to each jurisdiction. This study takes a step in the first direction, but larger samples and
expanded needs assessments are needed.
The major strength of this study was the randomized, non-intervention group to assess
differences between persons assigned to an SLW versus persons relinked to care on their own,
but the sample size was small and diminished further by initial surveillance investigation
eliminations, reducing effect size and power. Furthermore, original sample size calculations
estimated a large odds ratio which can only detect large effects, a shortcoming in practice, yet a
valuable lesson learned about the need for cross-jurisdictional data sharing about D2C program
results for improved methodology design and implementation. This study contributed important
knowledge by providing some of the first estimates of persons who return to care on their own.
Among the randomized subgroups, participants in the intervention were about half as likely to be
relinked to care by an SLW compared to those who returned to care on their own without the
intervention, although results were insignificant (P-value>0.05). The absence of any impact of
relinkage-to-care programs has been replicated in the few other studies with control groups. One
study out of in a Seattle clinic designed a historical control group and found that time to
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relinkage was significantly shorter among persons in the intervention group and had higher
relinkage rates in the intervention arm (15% vs. 10%), but this study had a year follow up period
which included relinkage to care with different measures of direct intervention assistance when
compared to this study.32 A cluster-randomized evaluation of another D2C initiative found no
difference between persons relinked to care and/or achieving viral suppression, with almost half
of their initial study population returning to care prior to attempted intervention contact.39
Researchers noted the lack of the control group in previous D2C studies might have led to false
perceptions of the effectiveness of D2C programs as originally reported, a conclusions this study
appears to support.39
Similar to the immediately aforementioned studies, our study found 46.6% of persons
contacted by SLWs self-reported already being in care, and given the non-intervention group was
dependent upon persons returning to care on their own, it is possible that excluding persons selfreporting being in care from the intervention group during the final analyses might impact the
final relationship of interest. However, given the circumstances, they were not relinked by the
SL Program, and it was not possible to determine if/when these persons might have truly
returned to care, nor was second surveillance investigation performed to confirm their current
care status. Future studies might consider alternative approaches to overcome this quandary.
This study employed a combination of surveillance-based, clinic-based, and internalbased referral sources to identify initially presumed, out-of-care persons, which uniquely allowed
for a comparison of potential differences between these sources in their D2C abilities.
Consistently, active referral sources, such as DIS-initiated or incoming OOJ referrals, had greater
odds of qualifying for SL follow up and successful relinkage to care. Unfortunately, this
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mechanism also produced the fewest incoming participants, so health departments might
consider leveraging their programmatic strengths to increase the availability of active referral
sources and efficiency of their use. Future programs might explore internal mechanisms
afforded by their own health departments, given existing and easily modifiable trainings, STD
clinical resources, educational resources, and established community relationships.
Although race and ethnicity was not significantly associated in final analyses with
outcomes of interest, other studies have found relationships with race/ethnicity and relinkage to
care, with one particularly noting non-white PLWH were associated with greater likelihood of
care reengagement.59,73 Evaluation of the HIV Care Continuum at the national level has
demonstrated that persons of color, particularly black, are disproportionately impacted by the
HIV epidemic.56,74 Within the black population, similar trends emerge regarding the
discrepancies of age, with younger populations being less likely to link to care, achieve retention,
and reach viral suppression, suggesting trends might be different with further research and better
sampling.56 This study also lacked complete data on transmission risk category and any data
regarding sexual orientation and gender identity (SOGI), highlighting the limitations of existing
data systems to properly collect and report this information, rendering these vulnerable
populations invisible to public health analysis and potential outreach. As of 2015, a nationwide
call to action was initiated by the Centers for Medicare and Medicaid Services under the
Meaningful Use program to update electronic health record systems with SOGI data
parameters,75,76 and as of 2016, the Health Resources and Services Administration has mandated
SOGI data collection and reporting for improved outcome measures. 77 Additional covariates of
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interest would strengthen understanding of the influencers on successful follow up and care
reengagement.
Future studies might quantify the cost of service linkage outreach as a monetary measure.
Colleting the total minutes spent on the phone during each call attempt could produce a
cumulative time unit which could be assigned a labor cost/minute. The time spent traveling to
each field address could also be assessed for the same unit output. Furthermore, the City of
Houston assigns a pre-designated mileage allocation for travel reimbursement. It is possible to
geocode the addresses and determine the total distances traveled by SLWs in their attempts to
contact potential out-of-care clients in addition to the cost of these outreach attempts and analyze
the yield in terms of relinkage success. 78,79 Additionally, stratifying these results by the
significant variables in these analyses might help determine if there are variations in certain
variables and determine if specific sub-populations are harder to reach and might need more
tailored approaches. Contact attempts should also not just be limited to phone and field visits but
additional expansion to emails and text messages, as successful pilot programs built around
linkage, relinkage, and retention have been initiated with additional follow up needed. 78
Additional limitations of the current study include using time since HIV diagnosis as a
proxy for age given it eliminates a true measure for this variable, but using this measure
strengthens the assumptions of the multivariable logistic regression model, the benefits outweigh
the potential loss of data. Categorization of continuous variables results in some loss of
information and loss of power, but the only variables retained permanently in the final analyses
in their categorical format were most recent CD4+ T-lymphocyte count and most recent viral
load laboratory result, and there was strong clinical and public health justification for this
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action.80 Confounding factors are of potential concern, and additional literature is needed.81
Limitations of the Firth penalized likelihood method include potential upwards bias. 82 However,
given that the Firth method offsets the restrictions of small sample sizes when using maximum
likelihood estimation in multivariable logistic regression analyses, the statistical gain overcomes
the primary weakness of the data. Additionally, given the exploratory nature of this pilot project,
much was learned about the lower than expected proportion of the outcome of interest, i.e.,
relinkage/return of PLWH to care, including both practical lessons learned and statistical
implications for recreating similar randomized interventions to determine if trends are repeatable.
More efforts are needed to enroll persons for larger samples sizes and more time might be
needed to allow for proper population estimates to occur. List-wise deletion of missing variables
might be biased with better methods available for handling these data, yet missing data were
small (<5%) and limited to few analyses, thereby minimizing its impact, if any. 83
CONCLUSION
Health departments contribute key information about the out-of-care population, but
these systems fall short in timeliness and completeness when it comes to producing the necessary
information needed to successfully contact this hard to reach population, requiring extensive
resource input and management. More information is needed about their reasons for falling out
of care to better assess their specific needs and the dynamics influencing the fluid nature of HIV
care in order to capture this population before they are lost from the medical system.
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APPENDICES
Appendix A. List of Definitions
Administratively Closed – Outcomes assigned via record searches only as determined by data
system information and not assigned to the intervention (i.e., the SL Program). Both the initial
cohort and the intervention subgroups could be administratively closed.
Qualified for SLW Assistance – Referrals without a surveillance investigation outcome from
online record searches qualified for the intervention (i.e., outreach by an SLW). These persons,
upon completion of the first surveillance investigation among the care and laboratory data
systems, did not have evidence of care in the immediate six months prior to the date of the
investigation and were presumed to be out of care. They also lacked evidence of any other
outcome such as incarceration, death, out of jurisdiction, etc. Non-intervention subgroup
members could also have database evidence of being truly out of care with no other outcome
based on the set parameters during the first surveillance investigation timeframe, but they were
never officially assigned to SLW assistance.
Intervention Subjects – A subgroup of incoming referrals from the surveillance (eHARS) referral
source. The eHARS referrals were randomly assigned an intervention or non-intervention status.
Intervention subgroup members were non-distinct from the other referrals in the study except for
their respective non-intervention arm. They were record searched in the same timeline as the
other study subjects, excluding the non-intervention subgroup, and assigned to the SLWs using
the same criteria for inclusion.
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Non-intervention Subjects – A subgroup of incoming referrals from the surveillance (eHARS)
referral source. The eHARS referrals were randomly assigned an intervention or nonintervention status. Non-intervention subgroup members were managed by the same initial
surveillance investigation criteria and timeline. However, if a non-intervention subject was
confirmed to be out of care, it was not assigned to an SLW. Instead, surveillance investigation
would re-occur after a 90-day period to determine if the non-intervention subject returned to care
without SLW intervention for comparison to the intervention members who were assigned to an
SLW for assistance with returning to care.
Surveillance Investigation (SI) – Electronic record searches among HIV care, surveillance, and
public records data systems to assess the following outcomes: evidence of care, incarcerated,
deceased, ineligible, or out of care within the previous six months. This step determined if
incoming referrals were currently considered out of care per available data systems and would
subsequently be assigned to an SLW and/or additional surveillance investigation if the referral
was assigned to the non-intervention subgroup.
Out of Care – A referral was determined to be out of care when there was no evidence of a CD4+
T-lymphocyte count and/or viral load laboratory result and/or HIV care appointment within the
previous six months of a surveillance investigation date. An incoming referral should have been
out of care for at least six months prior to the referral date (i.e., the date the referral was received
by the HHD) according to the referral source’s internal record system.
CD4+ T-lymphocyte count - A CD4+ T-lymphocyte count is a measure of the number of CD4+
cells (aka T-helper cells) in a sample of blood. A simple blood test can count the cells. CD4+
cells are a type of immune system cell in the body that HIV attacks and kills over time. It is
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considered a proxy of HIV care because a person’s CD4+ T-lymphocyte count increases as the
HIV virus is controlled through adherence to treatment and consistent medical care. 84,85
Therefore, conducting regular CD4+ T-lymphocyte count tests is considered a standard of HIV
care because it is a marker of a PLWH’s current health status.85–87
Viral Load – A viral load is the amount of virus in the blood. It is measured by a simple blood
test. Like a CD4+ T-lymphocyte count, treatment adherence influences a person’s viral load by
decreasing it to undetectable levels, serving as an indicator of consistent medical care. 84,85
Therefore, conducting regular viral load tests is considered a standard of HIV care because it is a
marker of a PLWH’s current health status.85–87
Service Linkage Worker (SLW) – SLWs are a type of non-medical case manager who, for the
purposes of this study intervention, contacted HIV-infected persons not currently receiving
medical care who were once in HIV care and facilitated the return of these persons to care.
Service Linkage (SL) Program – The SL Program houses the SLWs. In existence before the
implementation of this study, it was originally designed to assist with initial linkage to care for
newly diagnosed, HIV-positive persons.
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Appendix B. Logistic Regression Model
π(𝑥) =

𝑒 𝑥′𝛽
′
(1 + 𝑒 𝑥 𝛽 )

π(𝑥) is the probability of a Bernoulli random variable which takes the value 1 or 0 evaluating at
a covariate matrix x, and 𝛽 is the parameter vector48
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Appendix C. Firth correction: estimates 𝛽 as the maximum of the penalized loglikelihood
1
ℓ∗ (𝛽) = ℓ(𝛽) + 𝑙𝑛 |𝐼(𝛽)|
2
ℓ(𝛽) is the model loglikelihood, ½ln|I| is the penalty term48–50,82
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Appendix D. SAS 9.4 software code for Aim 1 multiple logistic regression results in Table 12
and associated diagnostics
proc logistic data=FULL2 order=data;
class Merck2 (ref="NO" param=ref) TAB3 (ref="PROV" param=ref) VL4
(ref="suppressed" param=ref) CD44 (ref="greater200" param=ref);
model Merck2=HIV2 TAB3 VL4 CD44 / selection=backward fast slstay=0.2
ctable lackfit rsq;
run;
ods graphics on;
proc logistic data=FULL2 order=data;
class Merck2 (ref="NO" param=ref) TAB3 (ref="PROV" param=ref) VL4
(ref="suppressed" param=ref) CD44 (ref="greater200" param=ref);
model Merck2=HIV2 TAB3 VL4 CD44 / lackfit rsq TECHNIQUE=NEWTON OUTROC=ROC
CLPARM=WALD CLODDS=WALD
SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK;
OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate);
effectplot slicefit;
run;
ods graphics on;
proc univariate data=pred;
histogram resdev reschi /
NORMAL (COLOR=red W=3
PERCENT=20 40 60 80
MIDPERCENTS) CFILL= blue
CFRAME= yellow;
RUN;
ods graphics on;
proc loess data=Test;
model Merck3=HIV2/smooth=0.1 0.25 0.4 0.6 residual;
ods output OutputStatistics=Results;
run;
proc loess data=Test;
model Merck3=HIV2 / details(ModelSummary OutputStatistics);
run;
proc reg data=Test;
model Merck3=HIV2 TAB5 VL CD4 / vif tol collin;
run;
proc corr data=Test spearman;
var AGE6 TAB5 VL CD4;
run;
proc corr data=Test pearson;
var HIV2 AGE2;
run;
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Appendix E. SAS 9.4 software code for Aim 1 multiple logistic regression results in Table 17
and associated diagnostics
proc logistic data=care order=data;
class DISPO3 (ref="outofcare" param=ref) TAB3 (ref="PROV" param=ref) VL4
(ref="suppressed" param=ref);
model DISPO3=HIV2 TAB3 VL4 / selection=backward fast slstay=0.2 ctable
lackfit rsq;
run;
ods graphics on;
proc logistic data=care order=data;
class DISPO3 (ref="outofcare" param=ref) TAB3 (ref="PROV" param=ref) VL4
(ref="suppressed" param=ref);
model DISPO3=HIV2 TAB3 VL4 / lackfit rsq TECHNIQUE=NEWTON OUTROC=ROC
CLPARM=WALD CLODDS=WALD
SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK;
OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate);
effectplot slicefit;
run;
ods graphics on;
proc loess data=Test2;
model DISPO=HIV2/smooth=0.1 0.25 0.4 0.6 residual;
ods output OutputStatistics=Results;
run;
proc loess data=Test;
model DISPO=HIV2 / details(ModelSummary OutputStatistics);
run;
proc reg data=Test2;
model DISPO=HIV2 TAB5 VL / vif tol collin;
run;
proc reg data=Test2;
model DISPO=HIV2 AGE6 TAB5 VL / vif tol collin;
run;
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Appendix F. SAS 9.4 software code for Aim 2 multiple logistic regression results in Table 23
and associated diagnostics
proc logistic data=SLWonly order=data;
class SLWDISPO2 (ref="Other" param=ref) TAB3 (ref = "PROV") CLIENT_PCS
(ref = "2orless") RACE2 (ref = "W") PROV_PCSS (ref = '0')
PROV_FVS (ref = "0") CD44 (ref="greater200"
param=ref)/ param=ref;
model SLWDISPO2=RACE2 TAB3 CD44 CLIENT_PCS / firth clodds=pl lackfit rsq;
effectplot;
run;
ods graphics on;
proc logistic data=SLWonly order=data;
class SLWDISPO2 (ref="Other" param=ref) TAB3 (ref = "PROV") CLIENT_PCS
(ref = "2orless") RACE2 (ref = "W") PROV_PCSS (ref = '0')
PROV_FVS (ref = "0") CD44 (ref="greater200"
param=ref)/ param=ref;
model SLWDISPO2=RACE2 TAB3 CD44 CLIENT_PCS / firth clodds=pl lackfit rsq
TECHNIQUE=NEWTON OUTROC=ROC CLPARM=WALD CLODDS=WALD
SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK;
OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate);
effectplot slicefit;
run;
ods graphics on;
proc univariate data=pred;
histogram resdev reschi /
NORMAL (COLOR=red W=3
PERCENT=20 40 60 80
MIDPERCENTS) CFILL= blue
CFRAME= yellow;
RUN;
proc reg data=Test2;
model DISPO=TAB5 RACES CD4 C_PCS / vif tol collin;
run;
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Appendix G. SAS 9.4 software code for Aim 2 multiple logistic regression results in Table 26
and associated diagnostics
proc logistic data=SLWonly order=data;
class SLWDISPO5 (ref="UnabletoLocate" param=ref) TAB3 (ref = "PROV")
CLIENT_PCS (ref = "2orless") CLIENT_FVS (ref = '0')
VL5 (ref = 'suppressed') / param=ref;
model SLWDISPO5= HIV2 TAB3 VL5 CLIENT_PCS CLIENT_FVS / firth clodds=pl
lackfit rsq;
effectplot;
run;
ods graphics on;
proc logistic data=SLWonly order=data;
class SLWDISPO5 (ref="UnabletoLocate" param=ref) TAB3 (ref = "PROV")
CLIENT_PCS (ref = "2orless") CLIENT_FVS (ref = '0')
VL5 (ref = 'suppressed') / param=ref;
model SLWDISPO5=TAB3 VL5 CLIENT_PCS CLIENT_FVS / lackfit rsq
TECHNIQUE=NEWTON OUTROC=ROC CLPARM=WALD CLODDS=WALD
SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK;
OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate);
effectplot slicefit;
run;
ods graphics on;
proc univariate data=pred;
histogram resdev reschi /
NORMAL (COLOR=red W=3
PERCENT=20 40 60 80
MIDPERCENTS) CFILL= blue
CFRAME= yellow;
RUN;
ods graphics on;
proc loess data=Test2;
model DISPOS2=HIV2/smooth=0.1 0.25 0.4 0.6 residual;
ods output OutputStatistics=Results;
run;
proc loess data=Test2;
model DISPOS2=HIV2 / details(ModelSummary OutputStatistics);
run;
proc reg data=Test2;
model DISPOS2=TAB5 VL C_PCS C_FVS / vif tol collin;
run;
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Appendix H. SAS 9.4 software code for Aim 3 multiple logistic regression results in Table 32
and associated diagnostics
proc logistic data=Final3 order=data;
class FINALDISPO ORIGIN (ref='90DAYONLY') ETH (ref='NH' param=ref) AGE5
(ref='44orless' param=ref);
model FINALDISPO=ORIGIN ETH AGE5 / firth clodds=pl lackfit rsq;
effectplot;
where Merck='YES';
run;
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Appendix I. SAS 9.4 software code for Aim 3 multiple logistic regression results in Table 33 and
associated diagnostics
proc logistic data=Final3 order=data;
class FINALDISPO ORIGIN (ref='90DAYONLY');
model FINALDISPO=ORIGIN/ firth clodds=pl lackfit rsq;
effectplot;
where Merck='YES';
run;
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